Differential	O
effects	O
of	O
protein	B-protein
kinase	I-protein
C	I-protein
inhibitors	O
on	O
fibronectin	B-protein
-induced	O
interleukin-beta	B-DNA
gene	I-DNA
transcription	O
,	O
protein	O
synthesis	O
and	O
secretion	O
in	O
human	B-cell_type
monocytic	I-cell_type
cells	I-cell_type
.	O

Human	B-cell_type
monocytic	I-cell_type
cells	I-cell_type
express	O
interleukin-1beta	B-protein
(	O
IL-1beta	B-protein
)	O
when	O
stimulated	O
with	O
the	O
extracellular	B-protein
matrix	I-protein
glycoprotein	I-protein
,	O
fibronectin	B-protein
(	O
FN	B-protein
)	O
.	O

Protein	B-protein
kinase	I-protein
C	I-protein
(	O
PKC	B-protein
)	O
activation	O
is	O
considered	O
important	O
for	O
this	O
process	O
;	O
however	O
,	O
the	O
metabolic	O
steps	O
at	O
which	O
PKC	B-protein
acts	O
upon	O
to	O
mediate	O
the	O
FN	B-protein
-induced	O
IL-1beta	B-protein
response	O
remain	O
unclear	O
.	O

We	O
performed	O
an	O
analysis	O
of	O
the	O
mechanisms	O
by	O
which	O
two	O
PKC	B-protein
inhibitors	O
,	O
Calphostin	O
C	O
and	O
Staurosporine	O
,	O
prevent	O
the	O
FN	B-protein
-induced	O
IL-1beta	B-protein
response	O
.	O

Both	O
inhibitors	O
blocked	O
the	O
secretion	O
of	O
IL-1beta	B-protein
protein	I-protein
into	O
the	O
media	O
of	O
peripheral	B-cell_type
blood	I-cell_type
mononuclear	I-cell_type
cells	I-cell_type
exposed	O
to	O
FN	B-protein
.	O

Immunoprecipitation	O
analysis	O
revealed	O
that	O
unde3r	O
these	O
circumstances	O
,	O
Calphostin	O
C	O
inhibited	O
the	O
production	O
of	O
IL-1beta	B-protein
protein	I-protein
,	O
whereas	O
Staurosporine	O
allowed	O
protein	O
production	O
,	O
but	O
inhibited	O
its	O
secretion	O
.	O

To	O
determine	O
the	O
mechanisms	O
responsible	O
for	O
these	O
differences	O
,	O
we	O
turned	O
to	O
human	B-cell_line
U937	I-cell_line
promonocytic	I-cell_line
cells	I-cell_line
.	O

U937	O
cells	O
transfected	O
with	O
the	O
human	O
full-length	B-DNA
IL-1beta	I-DNA
promoter	I-DNA
connected	O
to	O
a	O
luciferase	B-DNA
reporter	I-DNA
gene	I-DNA
were	O
submitted	O
to	O
transcription	O
assays	O
,	O
Northern	O
blotting	O
,	O
and	O
DNA	O
electrophoresis	O
mobility	O
gel	O
shift	O
assays	O
.	O

These	O
studies	O
revealed	O
that	O
Calphostin	O
C	O
inhibited	O
the	O
nuclear	O
translocation	O
of	O
the	O
transcription	B-protein
factor	I-protein
activator	I-protein
protein-1	I-protein
(	O
AP-1	B-protein
)	O
which	O
is	O
considered	O
necessary	O
for	O
FN	B-protein
induction	O
of	O
IL-1beta	B-protein
gene	O
transcription	O
,	O
and	O
prevented	O
the	O
transcription	O
of	O
the	O
IL-1beta	B-DNA
gene	I-DNA
.	O

In	O
contrast	O
,	O
Staurosporine	O
alone	O
induced	O
AP-1	B-protein
translocation	O
and	O
stimulation	O
of	O
the	O
gene	O
.	O

Overall	O
,	O
our	O
data	O
indicate	O
that	O
Calphostin	O
C	O
prevents	O
the	O
transcription	O
of	O
the	O
IL-1beta	B-DNA
gene	I-DNA
thereby	O
inhibiting	O
protein	O
synthesis	O
.	O

Based	O
on	O
the	O
high	O
specificity	O
of	O
this	O
compound	O
for	O
PKC	B-protein
,	O
we	O
conclude	O
that	O
PKC	B-protein
is	O
necessary	O
for	O
FN	B-protein
-induced	O
IL-1beta	B-protein
protein	O
production	O
.	O

In	O
contrast	O
,	O
Staurosporine	O
prevented	O
secretion	O
of	O
IL-1beta	B-protein
by	O
unknown	O
mechanisms	O

Immunology	NULL
1998	NULL
95	NULL
264-271	NULL
Differential	NULL
effects	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
inhibitors	NULL
on	NULL
fibronectin-induced	NULL
interleukin-f	NULL
gene	NULL
transcription	NULL
,	NULL
protein	NULL
synthesis	NULL
and	NULL
secretion	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
J.	NULL
RITZENTHALER	NULL
&	NULL
J.	NULL
ROMAN	NULL
Pulmonary	NULL
&	NULL
Critical	NULL
Care	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Atlanta	NULL
Veterans	NULL
Affairs	NULL
Medical	NULL
Center	NULL
and	NULL
Emory	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Atlanta	NULL
,	NULL
GA	NULL
,	NULL
USA	NULL
SUMMARY	NULL
Human	NULL
monocytic	NULL
cells	NULL
express	NULL
interleukin-1B	NULL
(	NULL
IL-1B	NULL
)	NULL
when	NULL
stimulated	NULL
with	NULL
the	NULL
extracellular	NULL
matrix	NULL
glycoprotein	NULL
,	NULL
fibronectin	NULL
(	NULL
FN	NULL
)	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
activation	NULL
is	NULL
considered	NULL
important	NULL
for	NULL
this	NULL
process	NULL
;	NULL
however	NULL
,	NULL
the	NULL
metabolic	NULL
steps	NULL
at	NULL
which	NULL
PKC	NULL
acts	NULL
upon	NULL
to	NULL
mediate	NULL
the	NULL
FN-induced	NULL
IL-1B	NULL
response	NULL
remain	NULL
unclear	NULL
.	NULL

We	NULL
performed	NULL
an	NULL
analysis	NULL
of	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
two	NULL
PKC	NULL
inhibitors	NULL
,	NULL
Calphostin	NULL
C	NULL
and	NULL
Staurosporine	NULL
,	NULL
prevent	NULL
the	NULL
FN-induced	NULL
IL-1B	NULL
response	NULL
.	NULL

Both	NULL
inhibitors	NULL
blocked	NULL
the	NULL
secretion	NULL
of	NULL
IL-1f	NULL
protein	NULL
into	NULL
the	NULL
media	NULL
of	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
exposed	NULL
to	NULL
FN	NULL
.	NULL

Immunoprecipitation	NULL
analysis	NULL
revealed	NULL
that	NULL
under	NULL
these	NULL
circumstances	NULL
,	NULL
Calphostin	NULL
C	NULL
inhibited	NULL
the	NULL
production	NULL
of	NULL
IL-1fB	NULL
protein	NULL
,	NULL
whereas	NULL
Staurosporine	NULL
allowed	NULL
protein	NULL
production	NULL
,	NULL
but	NULL
inhibited	NULL
its	NULL
secretion	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
mechanisms	NULL
responsible	NULL
for	NULL
these	NULL
differences	NULL
,	NULL
we	NULL
turned	NULL
to	NULL
human	NULL
U937	NULL
promonocytic	NULL
cells	NULL
.	NULL

U937	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
human	NULL
full-length	NULL
IL-1	NULL
B	NULL
promoter	NULL
connected	NULL
to	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
were	NULL
submitted	NULL
to	NULL
transcription	NULL
assays	NULL
,	NULL
Northern	NULL
blotting	NULL
,	NULL
and	NULL
DNA	NULL
electrophoresis	NULL
mobility	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

These	NULL
studies	NULL
revealed	NULL
that	NULL
Calphostin	NULL
C	NULL
inhibited	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
which	NULL
is	NULL
considered	NULL
necessary	NULL
for	NULL
FN	NULL
induction	NULL
of	NULL
IL-1	NULL
B	NULL
gene	NULL
transcription	NULL
,	NULL
and	NULL
prevented	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IL-1B	NULL
gene	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Staurosporine	NULL
alone	NULL
induced	NULL
AP-1	NULL
translocation	NULL
and	NULL
stimulation	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Overall	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
Calphostin	NULL
C	NULL
prevents	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IL-1B	NULL
gene	NULL
thereby	NULL
inhibiting	NULL
protein	NULL
synthesis	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
high	NULL
specificity	NULL
of	NULL
this	NULL
compound	NULL
for	NULL
PKC	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
PKC	NULL
is	NULL
necessary	NULL
for	NULL
FN-induced	NULL
IL-1	NULL
B	NULL
protein	NULL
production	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Staurosporine	NULL
prevented	NULL
secretion	NULL
of	NULL
IL-1B	NULL
by	NULL
unknown	NULL
mechanisms	NULL
.	NULL

INTRODUCTION	NULL
Interleukin-16	NULL
(	NULL
IL-1	NULL
B	NULL
)	NULL
is	NULL
a	NULL
potent	NULL
multifunctional	NULL
polypeptide	NULL
produced	NULL
by	NULL
monocytic	NULL
cells	NULL
.	NULL

!	NULL

This	NULL
cytokine	NULL
is	NULL
expressed	NULL
soon	NULL
after	NULL
tissue	NULL
injury	NULL
and	NULL
is	NULL
considered	NULL
important	NULL
for	NULL
establishment	NULL
and	NULL
maintenance	NULL
of	NULL
an	NULL
effective	NULL
inflammatory	NULL
response	NULL
.	NULL

``	NULL
~*	NULL
Fibronectin	NULL
(	NULL
FN	NULL
)	NULL
,	NULL
a	NULL
high	NULL
molecular	NULL
weight	NULL
connective	NULL
tissue	NULL
glycoprotein	NULL
,	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
IL-1B	NULL
production	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
.	NULL

``	NULL
©	NULL
Because	NULL
it	NULL
too	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
injured	NULL
tissues	NULL
,	NULL
FN	NULL
may	NULL
induce	NULL
IL-1f	NULL
production	NULL
in	NULL
vivo	NULL
which	NULL
could	NULL
serve	NULL
to	NULL
amplify	NULL
inflammation	NULL
.	NULL
``	NULL

However	NULL
,	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
FN	NULL
induces	NULL
IL-1B	NULL
have	NULL
not	NULL
been	NULL
entirely	NULL
elucidated	NULL
.	NULL

Received	NULL
3	NULL
March	NULL
1998	NULL
;	NULL
revised	NULL
24	NULL
June	NULL
1998	NULL
;	NULL
accepted	NULL
24	NULL
June	NULL
1998	NULL
.	NULL

Abbreviations	NULL
:	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
CC	NULL
,	NULL
Calphostin	NULL
C	NULL
;	NULL
FN	NULL
,	NULL
fibronectin	NULL
;	NULL
IL-1	NULL
$	NULL
,	NULL
interleukin-1f	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
PBMCs	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
ST	NULL
,	NULL
Staurosporine	NULL
.	NULL

Correspondence	NULL
:	NULL
Dr	NULL
J.	NULL
Roman	NULL
,	NULL
Atlanta	NULL
Veterans	NULL
Affairs	NULL
Medical	NULL
Center	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
(	NULL
111	NULL
)	NULL
,	NULL
Pulmonary	NULL
&	NULL
Critical	NULL
Care	NULL
Section	NULL
,	NULL
1670	NULL
Clairmont	NULL
Road	NULL
,	NULL
Decatur	NULL
,	NULL
GA	NULL
30033	NULL
,	NULL
USA	NULL
.	NULL

The	NULL
known	NULL
cellular	NULL
mechanisms	NULL
mediating	NULL
the	NULL
FN-induced	NULL
IL-1B	NULL
response	NULL
are	NULL
as	NULL
follows	NULL
.	NULL

Monocytic	NULL
cells	NULL
interact	NULL
with	NULL
FN	NULL
by	NULL
means	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cell	NULL
surface	NULL
glycoproteins	NULL
that	NULL
are	NULL
members	NULL
of	NULL
the	NULL
integrin	NULL
receptor	NULL
family	NULL
.	NULL
``	NULL

''	NULL
One	NULL
of	NULL
these	NULL
integrins	NULL
,	NULL
«	NULL
5B1	NULL
,	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
IL-1B	NULL
by	NULL
FN	NULL
.	NULL

*°	NULL
Once	NULL
bound	NULL
by	NULL
FN	NULL
,	NULL
the	NULL
activated	NULL
integrin	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
trans-acting	NULL
factor	NULL
activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
(	NULL
a	NULL
product	NULL
of	NULL
the	NULL
proto-oncogene	NULL
c-jun	NULL
)	NULL
which	NULL
is	NULL
responsible	NULL
for	NULL
induction	NULL
of	NULL
IL-1B	NULL
gene	NULL
transcription	NULL
and	NULL
accumulation	NULL
of	NULL
IL-1B	NULL
mRNA	NULL
(	NULL
Roman	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

The	NULL
IL-1B	NULL
mRNA	NULL
is	NULL
then	NULL
translated	NULL
into	NULL
the	NULL
IL-1B	NULL
precursor	NULL
protein	NULL
(	NULL
31000	NULL
MW	NULL
)	NULL
followed	NULL
by	NULL
cleavage	NULL
and	NULL
secretion	NULL
of	NULL
the	NULL
17000	NULL
MW	NULL
bioactive	NULL
The	NULL
early	NULL
signalling	NULL
events	NULL
that	NULL
follow	NULL
FN-	NULL
«	NULL
5B1	NULL
binding	NULL
and	NULL
lead	NULL
to	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
IL-1B	NULL
gene	NULL
and	NULL
secretion	NULL
of	NULL
the	NULL
protein	NULL
remain	NULL
poorly	NULL
understood	NULL
,	NULL
but	NULL
protein	NULL
kinases	NULL
are	NULL
believed	NULL
to	NULL
be	NULL
important	NULL
.	NULL
``	NULL

''	NULL
One	NULL
protein	NULL
kinase	NULL
linked	NULL
experimentally	NULL
to	NULL
the	NULL
FN-induced	NULL
IL-1B	NULL
response	NULL
is	NULL
the	NULL
serine/threonine	NULL
kinase	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
.	NULL
``	NULL

We	NULL
set	NULL
out	NULL
to	NULL
explore	NULL
the	NULL
metabolic	NULL
steps	NULL
in	NULL
FN-induced	NULL
IL-1B	NULL
production	NULL
that	NULL
are	NULL
affected	NULL
by	NULL
two	NULL
commonly	NULL
used	NULL
PKC	NULL
inhibitors	NULL
:	NULL
Calphostin	NULL
C	NULL
(	NULL
CC	NULL
)	NULL
and	NULL
Stauroporine	NULL
(	NULL
St	NULL
)	NULL
.	NULL

©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
Protein	NULL
kinase	NULL
C	NULL
and	NULL
fibronectin-induced	NULL
IL-1	NULL
$	NULL
265	NULL
Calphostin	NULL
C	NULL
is	NULL
a	NULL
photoactivatable	NULL
regulatory	NULL
site	NULL
inhibitor	NULL
that	NULL
competes	NULL
with	NULL
endogenous	NULL
regulators	NULL
of	NULL
the	NULL
kinase	NULL
and	NULL
with	NULL
diacylglycerol	NULL
,	NULL
thereby	NULL
specifically	NULL
preventing	NULL
PKC	NULL
acti-vation	NULL
.	NULL

'*	NULL
``	NULL
*	NULL
Staurosporine	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
is	NULL
a	NULL
chemically	NULL
synthesized	NULL
indolocarbazole	NULL
derived	NULL
from	NULL
fungal	NULL
metabolites	NULL
that	NULL
is	NULL
not	NULL
selective	NULL
for	NULL
PKC	NULL
.	NULL

This	NULL
catalytic	NULL
site	NULL
inhibitor	NULL
acts	NULL
by	NULL
competing	NULL
for	NULL
adenosine	NULL
triphosphate	NULL
at	NULL
the	NULL
active	NULL
site	NULL
of	NULL
PKC	NULL
and	NULL
other	NULL
kinases	NULL
.	NULL

'*	NULL
``	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
Fibronectin	NULL
was	NULL
isolated	NULL
from	NULL
bovine	NULL
plasma	NULL
by	NULL
affinity	NULL
chromatography	NULL
using	NULL
gelatin-sepharose	NULL
as	NULL
previously	NULL
des-cribed	NULL
.	NULL
'	NULL

''	NULL
Preparations	NULL
of	NULL
FN	NULL
were	NULL
>	NULL
99	NULL
%	NULL
pure	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
.	NULL

Calphostin	NULL
C	NULL
was	NULL
purchased	NULL
from	NULL
Calbiochem-Novabiochem	NULL
Corporation	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
Staurosporine	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Company	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

A	NULL
goat	NULL
anti-human	NULL
polyclonal	NULL
antibody	NULL
to	NULL
IL-1B	NULL
(	NULL
ab201	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

All	NULL
other	NULL
reagents	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Company	NULL
or	NULL
Fisher	NULL
Scientific	NULL
(	NULL
Pittsburgh	NULL
,	NULL
PA	NULL
)	NULL
unless	NULL
otherwise	NULL
specified	NULL
.	NULL

Treatment	NULL
of	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
and	NULL
U937	NULL
cells	NULL
Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
were	NULL
isolated	NULL
by	NULL
elutriation	NULL
on	NULL
a	NULL
polysucrose	NULL
diatrizoate	NULL
column	NULL
(	NULL
Histopaque	NULL
1077	NULL
)	NULL
under	NULL
sterile	NULL
conditions	NULL
and	NULL
maintained	NULL
in	NULL
RPMI-1640	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Each	NULL
experiment	NULL
was	NULL
separate	NULL
and	NULL
performed	NULL
at	NULL
least	NULL
four	NULL
times	NULL
using	NULL
freshly	NULL
isolated	NULL
PBMC	NULL
from	NULL
healthy	NULL
non-smoking	NULL
volunteers	NULL
.	NULL

Previous	NULL
studies	NULL
involving	NULL
PBMCs	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
cell	NULL
type	NULL
responsible	NULL
for	NULL
the	NULL
IL-1	NULL
B	NULL
production	NULL
and	NULL
activity	NULL
was	NULL
the	NULL
monocyte	NULL
and	NULL
that	NULL
the	NULL
lymphocytes	NULL
present	NULL
did	NULL
not	NULL
effect	NULL
this	NULL
response.©	NULL
Therefore	NULL
,	NULL
PBMCs	NULL
were	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
without	NULL
further	NULL
purification	NULL
.	NULL

Human	NULL
monocytic/macrophage	NULL
cells	NULL
from	NULL
histiocytic	NULL
lym-phoma	NULL
,	NULL
U937	NULL
(	NULL
ATCC	NULL
CRL	NULL
no	NULL
.	NULL

1593	NULL
;	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
were	NULL
used	NULL
for	NULL
studies	NULL
directed	NULL
at	NULL
investigating	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
PKC	NULL
inhibitors	NULL
on	NULL
FN-induced	NULL
IL-1B	NULL
gene	NULL
transcription	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI-1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat	NULL
inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
,	NULL
1	NULL
%	NULL
antiobiotic-antimycotic	NULL
(	NULL
100	NULL
U/ml	NULL
penicillin	NULL
G	NULL
sodium	NULL
,	NULL
100	NULL
U/ral	NULL
streptomycin	NULL
sulfate	NULL
,	NULL
0-25	NULL
ug/ml	NULL
amphotericin	NULL
B	NULL
)	NULL
and	NULL
incubated	NULL
in	NULL
a	NULL
humidified	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
incubator	NULL
at	NULL
37°	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
at	NULL
4x	NULL
10°	NULL
cells	NULL
per	NULL
group	NULL
with	NULL
soluble	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-free	NULL
FN	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
for	NULL
16	NULL
hr	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
PKC	NULL
inhibitors	NULL
,	NULL
unless	NULL
otherwise	NULL
specified	NULL
.	NULL

FN	NULL
was	NULL
used	NULL
at	NULL
100	NULL
ug/ml	NULL
because	NULL
this	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
concentration	NULL
needed	NULL
to	NULL
maximally	NULL
stimulate	NULL
IL-1B	NULL
production	NULL
.	NULL
``	NULL

Cells	NULL
were	NULL
pretreated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
St	NULL
and	NULL
CC	NULL
at	NULL
1x	NULL
10~	NULL
'	NULL
m.	NULL
Post-treatment	NULL
cell	NULL
counts	NULL
on	NULL
representative	NULL
samples	NULL
showed	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
cell	NULL
number	NULL
when	NULL
these	NULL
agents	NULL
were	NULL
used	NULL
at	NULL
this	NULL
concentration	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
judged	NULL
to	NULL
be	NULL
>	NULL
95	NULL
%	NULL
viable	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Screening	NULL
for	NULL
LPS	NULL
Strict	NULL
measures	NULL
were	NULL
taken	NULL
to	NULL
avoid	NULL
LPS	NULL
contamination	NULL
.	NULL

When	NULL
necessary	NULL
,	NULL
experimental	NULL
reagents	NULL
were	NULL
reconstituted	NULL
in	NULL
LPS	NULL
©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
95	NULL
,	NULL
264-271	NULL
free	NULL
water	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

All	NULL
treatment	NULL
materials	NULL
and	NULL
culture	NULL
media	NULL
were	NULL
screened	NULL
with	NULL
a	NULL
limulus-based	NULL
endotoxin	NULL
assay	NULL
with	NULL
a	NULL
sensitivity	NULL
of	NULL
0:06	NULL
ng/ml	NULL
(	NULL
Endotect-Schwarz/Mann	NULL
Biotech	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

The	NULL
sensitivity	NULL
of	NULL
this	NULL
screening	NULL
tool	NULL
falls	NULL
within	NULL
the	NULL
accepted	NULL
background	NULL
levels	NULL
of	NULL
other	NULL
endotoxin	NULL
assays	NULL
for	NULL
LPS	NULL
.	NULL
``	NULL

In	NULL
contaminated	NULL
samples	NULL
,	NULL
LPS	NULL
was	NULL
removed	NULL
by	NULL
rotation	NULL
at	NULL
4°	NULL
in	NULL
B-52	NULL
END-X	NULL
endotoxin-removal	NULL
devices	NULL
(	NULL
Associates	NULL
of	NULL
Cape	NULL
Cod	NULL
,	NULL
Inc.	NULL
,	NULL
Woods	NULL
Hole	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
quantitated	NULL
by	NULL
absorbance	NULL
at	NULL
an	NULL
optimal	NULL
density	NULL
(	NULL
OD	NULL
)	NULL
of	NULL
280	NULL
nm	NULL
and	NULL
reassessed	NULL
for	NULL
endotoxin	NULL
contamination	NULL
.	NULL

Proteins	NULL
treated	NULL
in	NULL
this	NULL
fashion	NULL
were	NULL
deemed	NULL
intact	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
molecular	NULL
weight	NULL
changes	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
original	NULL
protein	NULL
on	NULL
SDS-PAGE	NULL
,	NULL
.	NULL

IL-1	NULL
$	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
Immunoreactive	NULL
protein	NULL
present	NULL
in	NULL
the	NULL
supernatant	NULL
of	NULL
treated	NULL
cells	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
sandwich	NULL
ELISA	NULL
assay	NULL
for	NULL
human	NULL
IL-1	NULL
B	NULL
(	NULL
Quantikine	NULL
,	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Pulse-chase	NULL
immunoprecipitation	NULL
analysis	NULL
of	NULL
IL-1B	NULL
in	NULL
PBMCs	NULL
Monocytes	NULL
were	NULL
isolated	NULL
by	NULL
adhesion	NULL
of	NULL
PBMCs	NULL
to	NULL
plastic	NULL
culture	NULL
dishes	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°	NULL
.	NULL

Cells	NULL
were	NULL
pretreated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
or	NULL
without	NULL
St	NULL
and	NULL
CC	NULL
at	NULL
1	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
100	NULL
ug/ml	NULL
of	NULL
endotoxin-free	NULL
FN	NULL
for	NULL
1	NULL
hr	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
modified	NULL
complete	NULL
media	NULL
(	NULL
RPMI-1640	NULL
with	NULL
1	NULL
%	NULL
heat	NULL
inactivated	NULL
FBS	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
methion-ine-free	NULL
media	NULL
containing	NULL
FN	NULL
,	NULL
PKC	NULL
inhibitors	NULL
,	NULL
and	NULL
supplemented	NULL
with	NULL
100	NULL
uCi/ml	NULL
**S-methionine	NULL
for	NULL
an	NULL
additional	NULL
90	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
,	NULL
incubated	NULL
in	NULL
fresh	NULL
RPMI-1640	NULL
media	NULL
containing	NULL
FN	NULL
and	NULL
PKC	NULL
inhibitors	NULL
for	NULL
16	NULL
hr	NULL
and	NULL
IL-1B	NULL
was	NULL
immunoprecipitated	NULL
using	NULL
10	NULL
ug/ml	NULL
of	NULL
control	NULL
immuno-globulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
or	NULL
a	NULL
goat	NULL
antibody	NULL
to	NULL
human	NULL
IL-1B	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
no	NULL
.	NULL

ab201	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

RNA	NULL
Isolation	NULL
and	NULL
Northern	NULL
Blotting	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
U937	NULL
cells	NULL
using	NULL
the	NULL
method	NULL
of	NULL
Chomezynski	NULL
&	NULL
Sacchi	NULL
.	NULL
``	NULL

Cells	NULL
were	NULL
pretreated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
or	NULL
without	NULL
St	NULL
and	NULL
CC	NULL
at	NULL
1	NULL
x	NULL
107	NULL
``	NULL
m	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
or	NULL
without	NULL
FN	NULL
and	NULL
PKC	NULL
inhibitors	NULL
for	NULL
2	NULL
hr	NULL
prior	NULL
to	NULL
harvest	NULL
.	NULL

Agarose	NULL
gel	NULL
electrophoresis	NULL
and	NULL
Northern	NULL
blotting	NULL
were	NULL
performed	NULL
following	NULL
published	NULL
methods	NULL
``	NULL
and	NULL
modified	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Electroporation	NULL
and	NULL
measurement	NULL
of	NULL
luciferase	NULL
activity	NULL
U937	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
40	NULL
ml	NULL
Cellgro	NULL
complete	NULL
serum-free	NULL
media	NULL
and	NULL
added	NULL
to	NULL
the	NULL
same	NULL
media	NULL
(	NULL
MediaTech	NULL
,	NULL
Herdon	NULL
,	NULL
VA	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
mm	NULL
dextrose	NULL
and	NULL
0-1	NULL
mm	NULL
DTT	NULL
to	NULL
a	NULL
final	NULL
cell	NULL
concentration	NULL
of	NULL
6x	NULL
10	NULL
``	NULL
cells/ml	NULL
.	NULL

U937	NULL
cells	NULL
(	NULL
48x	NULL
10	NULL
'	NULL
cells	NULL
)	NULL
were	NULL
electroporated	NULL
with	NULL
40	NULL
ug	NULL
pIL-1	NULL
(	NULL
4-0	NULL
kb	NULL
)	NULL
LUC	NULL
plasmid	NULL
DNA	NULL
and	NULL
20	NULL
ug	NULL
B-galactosidase	NULL
plasmid	NULL
DNA	NULL
at	NULL
400	NULL
V	NULL
and	NULL
1075	NULL
uF	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulse	NULL
II	NULL
Electroporation	NULL
_	NULL
system	NULL
-	NULL
(	NULL
Bio-Rad	NULL
,	NULL
-	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Electroporated	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
recover	NULL
for	NULL
1	NULL
hr	NULL
,	NULL
pretreated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
or	NULL
without	NULL
St	NULL
and	NULL
CC	NULL
at	NULL
1	NULL
x	NULL
10~	NULL
'	NULL
m	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
FN	NULL
and	NULL
PKC	NULL
inhibitors	NULL
for	NULL
16	NULL
hr	NULL
at	NULL
37°	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
100	NULL
pl	NULL
cell	NULL
lysis	NULL
buffer	NULL
(	NULL
25	NULL
mm	NULL
Tris-phosphate	NULL
,	NULL
pH	NULL
7-8	NULL
,	NULL
2	NULL
mm	NULL
DTT	NULL
,	NULL
2	NULL
mm	NULL
1,2-diaminocyclohexane-N	NULL
,	NULL
N	NULL
,	NULL
N	NULL
'	NULL
N'-tetraacetic	NULL
acid	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
Trixon	NULL
X-100	NULL
)	NULL
.	NULL

An	NULL
aliquot	NULL
(	NULL
20	NULL
ul	NULL
)	NULL
was	NULL
added	NULL
to	NULL
50	NULL
ul	NULL
luciferase	NULL
assay	NULL
reagent	NULL
[	NULL
20	NULL
mm	NULL
266	NULL
J.	NULL
Ritzenthaler	NULL
&	NULL
J.	NULL
Roman	NULL
tricine	NULL
,	NULL
1:07	NULL
mm	NULL
(	NULL
MgCO	NULL
;	NULL
)	NULL
,	NULL
Mg	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
5H	NULL
;	NULL
,0	NULL
,	NULL
2:67	NULL
mm	NULL
MgSO	NULL
,	NULL
0-1	NULL
mm	NULL
EDTA	NULL
,	NULL
33+3	NULL
mm	NULL
DTT	NULL
,	NULL
270	NULL
um	NULL
coenzyme	NULL
A	NULL
,	NULL
470	NULL
um	NULL
luciferin	NULL
,	NULL
530	NULL
um	NULL
(	NULL
ATP	NULL
)	NULL
]	NULL
and	NULL
tested	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
a	NULL
Dynatech	NULL
ML	NULL
3000	NULL
microtitre	NULL
plate	NULL
luminometer	NULL
(	NULL
Dynatech	NULL
Laboratories	NULL
Inc.	NULL
,	NULL
Chantilly	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

Results	NULL
were	NULL
recorded	NULL
as	NULL
relative	NULL
luciferase	NULL
units	NULL
and	NULL
standardized	NULL
for	NULL
transfection	NULL
efficiency	NULL
using	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Samples	NULL
were	NULL
normalized	NULL
to	NULL
total	NULL
protein	NULL
measured	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
using	NULL
Coomassie	NULL
blue	NULL
G-250	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL
``	NULL

DNA	NULL
electrophoresis	NULL
mobility	NULL
gel	NULL
shift	NULL
assay	NULL
U937	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
pretreated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
or	NULL
without	NULL
St	NULL
and	NULL
CC	NULL
at	NULL
1	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
and	NULL
grown	NULL
with	NULL
or	NULL
without	NULL
FN	NULL
and	NULL
PKC	NULL
inhibitors	NULL
at	NULL
37°	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
incubator	NULL
for	NULL
16	NULL
hr	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
with	NULL
ice	NULL
cold	NULL
PBS	NULL
and	NULL
nuclear	NULL
binding	NULL
proteins	NULL
were	NULL
extracted	NULL
using	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
DNA	NULL
electrophoresis	NULL
mobility	NULL
gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Radio-labelled	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
extracted	NULL
from	NULL
gels	NULL
and	NULL
quantitated	NULL
by	NULL
scintillation	NULL
counter	NULL
.	NULL

Statistical	NULL
evaluation	NULL
Means	NULL
+standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
were	NULL
calculated	NULL
for	NULL
all	NULL
experimental	NULL
values	NULL
.	NULL

Significance	NULL
was	NULL
assessed	NULL
using	NULL
P-values	NULL
obtained	NULL
by	NULL
means	NULL
of	NULL
a	NULL
two-tailed	NULL
Student	NULL
's	NULL
t-test	NULL
.	NULL

RESULTS	NULL
The	NULL
effects	NULL
of	NULL
CC	NULL
and	NULL
St	NULL
on	NULL
IL-	NULL
protein	NULL
secretion	NULL
in	NULL
FN-treated	NULL
PBMCs	NULL
Using	NULL
a	NULL
modified	NULL
enzyme-linked	NULL
immunoassay	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
CC	NULL
and	NULL
St	NULL
on	NULL
the	NULL
FN-induced	NULL
IL-1	NULL
$	NULL
B	NULL
response	NULL
.	NULL

As	NULL
previously	NULL
described	NULL
,	NULL
``	NULL
``	NULL
FN	NULL
induced	NULL
the	NULL
accumulation	NULL
of	NULL
IL-1B	NULL
protein	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
PBMCs	NULL
.	NULL

This	NULL
response	NULL
was	NULL
consistently	NULL
inhibited	NULL
by	NULL
St	NULL
and	NULL
CC	NULL
when	NULL
these	NULL
agents	NULL
were	NULL
added	NULL
prior	NULL
to	NULL
FN	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

la	NULL
,	NULL
b	NULL
)	NULL
.	NULL

Inactivated	NULL
CC	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
FN-induced	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

1b	NULL
,	NULL
FN/CC	NULL
)	NULL
.	NULL

W7	NULL
(	NULL
Fig	NULL
.	NULL

lc	NULL
)	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
calmodulin-dependent	NULL
protein	NULL
kinase	NULL
,	NULL
and	NULL
nifedipine	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
a	NULL
voltage-dependent	NULL
calcium	NULL
channel	NULL
blocker	NULL
,	NULL
were	NULL
unable	NULL
to	NULL
block	NULL
the	NULL
increased	NULL
production	NULL
of	NULL
IL-1f	NULL
in	NULL
response	NULL
to	NULL
FN	NULL
.	NULL

Note	NULL
that	NULL
,	NULL
although	NULL
the	NULL
amount	NULL
of	NULL
IL-1B	NULL
found	NULL
in	NULL
stimulated	NULL
cells	NULL
was	NULL
consistently	NULL
significantly	NULL
higher	NULL
than	NULL
controls	NULL
(	NULL
P	NULL
<	NULL
0-05	NULL
)	NULL
,	NULL
there	NULL
was	NULL
variability	NULL
in	NULL
the	NULL
IL-1B	NULL
response	NULL
to	NULL
FN	NULL
with	NULL
measured	NULL
levels	NULL
ranging	NULL
from	NULL
1500	NULL
to	NULL
over	NULL
8000	NULL
pg/ml	NULL
as	NULL
previously	NULL
demonstrated	NULL
.	NULL
``	NULL

The	NULL
exact	NULL
cause	NULL
for	NULL
this	NULL
variability	NULL
is	NULL
unknown	NULL
but	NULL
suggests	NULL
different	NULL
states	NULL
of	NULL
responsiveness	NULL
depending	NULL
on	NULL
the	NULL
source	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Effects	NULL
of	NULL
CC	NULL
and	NULL
St	NULL
on	NULL
FN-induced	NULL
IL-1	NULL
$	NULL
protein	NULL
synthesis	NULL
and	NULL
secretion	NULL
in	NULL
PBMC	NULL
We	NULL
then	NULL
evaluated	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
two	NULL
PKC	NULL
inhibitors	NULL
on	NULL
FN-induced	NULL
IL-16B	NULL
synthesis	NULL
and	NULL
secretion	NULL
using	NULL
pulse-chase	NULL
analysis	NULL
followed	NULL
by	NULL
immunoprecipitation	NULL
.	NULL

Figure	NULL
2	NULL
shows	NULL
a	NULL
representative	NULL
example	NULL
of	NULL
these	NULL
experiments	NULL
where	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
Staurosporine	NULL
(	NULL
St	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
or	NULL
activated	NULL
Calphostin	NULL
C	NULL
(	NULL
CC	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
at	NULL
1x	NULL
10~	NULL
'	NULL
m	NULL
followed	NULL
by	NULL
exposure	NULL
to	NULL
100	NULL
ug/ml	NULL
FN	NULL
for	NULL
16	NULL
hr	NULL
.	NULL

Cell	NULL
extracts	NULL
and	NULL
supernatants	NULL
(	NULL
Sup	NULL
)	NULL
were	NULL
immunoprecipated	NULL
separately	NULL
with	NULL
an	NULL
antibody	NULL
to	NULL
IL-1B	NULL
or	NULL
with	NULL
control	NULL
IgG	NULL
.	NULL

Note	NULL
that	NULL
no	NULL
(	NULL
a	NULL
)	NULL
$	NULL
000	NULL
2000	NULL
C	NULL
FN	NULL
_	NULL
FN/St	NULL
_	NULL
St	NULL
(	NULL
b	NULL
)	NULL
1500	NULL
7	NULL
1000	NULL
7	NULL
IL-1B	NULL
(	NULL
pg/m	NULL
!	NULL
)	NULL

500	NULL
C	NULL
_	NULL
FN	NULL
_	NULL
FN/CC*	NULL
FN/CC	NULL
6000	NULL
JG	NULL
)	NULL
T	NULL
5000	NULL
o	NULL
C	NULL
FN	NULL
-	NULL
FN/W7	NULL
w7	NULL
Figure	NULL
1	NULL
.	NULL

Effect	NULL
of	NULL
Stauroporine	NULL
,	NULL
Calphostin	NULL
C	NULL
,	NULL
and	NULL
W7	NULL
on	NULL
the	NULL
FN-induced	NULL
IL-1	NULL
}	NULL
response	NULL
.	NULL

Isolated	NULL
PBMCs	NULL
(	NULL
4x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
pretreated	NULL
with	NULL
Staurosporine	NULL
(	NULL
St	NULL
)	NULL
(	NULL
a	NULL
)	NULL
,	NULL
activated	NULL
(	NULL
CC®	NULL
)	NULL
or	NULL
inactivated	NULL
(	NULL
CC	NULL
)	NULL
Calphostin	NULL
C	NULL
(	NULL
b	NULL
)	NULL
,	NULL
or	NULL
W7	NULL
(	NULL
c	NULL
)	NULL
at	NULL
1	NULL
x	NULL
107	NULL
``	NULL
M	NULL
each	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
or	NULL
without	NULL
100	NULL
ug/ml	NULL
soluble	NULL
LPS-free	NULL
FN	NULL
for	NULL
16	NULL
hr	NULL
in	NULL
RPMI-1640	NULL
media	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
IL-1B	NULL
protein	NULL
(	NULL
expressed	NULL
as	NULL
pg/ml	NULL
)	NULL
was	NULL
analysed	NULL
by	NULL
enzyme-linked	NULL
immunoassay	NULL
.	NULL

Results	NULL
represent	NULL
at	NULL
least	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

Note	NULL
that	NULL
FN	NULL
induced	NULL
the	NULL
accumulation	NULL
of	NULL
IL-1B	NULL
protein	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
PBMCs	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
control	NULL
.	NULL

Both	NULL
St	NULL
and	NULL
CC	NULL
inhibited	NULL
this	NULL
stimulatory	NULL
effect	NULL
,	NULL
whereas	NULL
inactive	NULL
CC	NULL
and	NULL
W7	NULL
did	NULL
not	NULL
.	NULL

W7	NULL
appeared	NULL
to	NULL
enhance	NULL
the	NULL
response	NULL
.	NULL

material	NULL
was	NULL
immunoprecipitated	NULL
by	NULL
the	NULL
control	NULL
IgG	NULL
in	NULL
a	NULL
sample	NULL
of	NULL
cell	NULL
extract	NULL
obtained	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
FN	NULL
(	NULL
Cell	NULL
Extract	NULL
,	NULL
FN*	NULL
,	NULL
first	NULL
left	NULL
lane	NULL
)	NULL
.	NULL

The	NULL
following	NULL
was	NULL
found	NULL
when	NULL
the	NULL
anti	NULL
IL-1	NULL
B	NULL
antibody	NULL
was	NULL
used	NULL
.	NULL

No	NULL
IL-1	NULL
B	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
cell	NULL
extracts	NULL
of	NULL
FN-treated	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
inhibitors	NULL
(	NULL
Cell	NULL
Extract	NULL
,	NULL
FN	NULL
)	NULL
;	NULL
however	NULL
,	NULL
both	NULL
precursor	NULL
(	NULL
31000	NULL
MW	NULL
)	NULL
and	NULL
active	NULL
(	NULL
17000	NULL
MW	NULL
)	NULL
forms	NULL
of	NULL
IL-1B	NULL
(	NULL
the	NULL
latter	NULL
being	NULL
predominant	NULL
)	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
Sup	NULL
,	NULL
FN	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cell	NULL
extracts	NULL
obtained	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
St	NULL
prior	NULL
to	NULL
exposure	NULL
to	NULL
FN	NULL
showed	NULL
increased	NULL
amounts	NULL
of	NULL
precursor	NULL
IL-1B	NULL
protein	NULL
(	NULL
Cell	NULL
Extract	NULL
,	NULL
FN/St	NULL
)	NULL
,	NULL
but	NULL
no	NULL
IL-1	NULL
was	NULL
detected	NULL
in	NULL
their	NULL
supernatants	NULL
(	NULL
Sup	NULL
,	NULL
FN/St	NULL
)	NULL
.	NULL

In	NULL
other	NULL
words	NULL
,	NULL
PBMCs	NULL
exposed	NULL
to	NULL
FN	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
inhibitors	NULL
synthesized	NULL
and	NULL
secreted	NULL
IL-1	NULL
B	NULL
protein	NULL
with	NULL
little	NULL
IL-1B	NULL
remaining	NULL
intracellularly	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
experiment	NULL
.	NULL

©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
95	NULL
,	NULL
264-271	NULL
Protein	NULL
kinase	NULL
C	NULL
and	NULL
fibronectin-induced	NULL
IL-1	NULL
$	NULL
Staurosporin	NULL
(	NULL
St	NULL
)	NULL
267	NULL
Calphostin	NULL
C	NULL
(	NULL
CC	NULL
)	NULL
Cell	NULL
extract	NULL
Sup	NULL
Cell	NULL
extract	NULL
Sup	NULL
|	NULL
1	NULL
1	NULL
{	NULL
1	NULL
I	NULL
1	NULL
I	NULL
IL-1B	NULL
(	NULL
31	NULL
000	NULL
MW	NULL
)	NULL
P	NULL
-	NULL
30000	NULL
MW	NULL
#	NULL
@	NULL
(	NULL
IL-1	NULL
B	NULL
(	NULL
17000	NULL
MW	NULL
)	NULL
|	NULL
N	NULL
]	NULL
L______JL_____J	NULL
FN*	NULL
FN	NULL
FN	NULL
FN	NULL
FN	NULL
FN	NULL
FN	NULL
St	NULL
St	NULL
CC	NULL
CC	NULL
Figure	NULL
2	NULL
.	NULL

Effects	NULL
of	NULL
Staurosporine	NULL
on	NULL
IL-1B	NULL
protein	NULL
synthesis	NULL
and	NULL
secretion	NULL
.	NULL

Isolated	NULL
PBMCs	NULL
(	NULL
4	NULL
x	NULL
10®	NULL
cells	NULL
)	NULL
were	NULL
pretreated	NULL
with	NULL
Staurosporine	NULL
(	NULL
St	NULL
)	NULL
or	NULL
activated	NULL
Calphostin	NULL
C	NULL
(	NULL
CC	NULL
)	NULL
at	NULL
1	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
or	NULL
without	NULL
100	NULL
ug/ml	NULL
soluble	NULL
LPS-free	NULL
FN	NULL
(	NULL
FN	NULL
)	NULL
for	NULL
1	NULL
hr	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
modified	NULL
complete	NULL
media	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
an	NULL
additional	NULL
90	NULL
min	NULL
in	NULL
methionine	NULL
free	NULL
media	NULL
containing	NULL
FN	NULL
,	NULL
PKC	NULL
inhibitors	NULL
and	NULL
supplemented	NULL
with	NULL
100	NULL
pCi/ml	NULL
*S	NULL
methionine	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
,	NULL
incubated	NULL
in	NULL
fresh	NULL
RPMI-1640	NULL
media	NULL
containing	NULL
FN	NULL
and	NULL
PKC	NULL
inhibitors	NULL
for	NULL
16	NULL
hr	NULL
and	NULL
labelled	NULL
IL-1B	NULL
from	NULL
cell	NULL
extracts	NULL
or	NULL
supernatants	NULL
(	NULL
Sup	NULL
)	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
10	NULL
ug/ml	NULL
of	NULL
control	NULL
IgG	NULL
(	NULL
FN*	NULL
)	NULL
or	NULL
goat-anti	NULL
human	NULL
IL-1B	NULL
antibody	NULL
using	NULL
Protein	NULL
G-coated	NULL
sepharose	NULL
beads	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
boiled	NULL
in	NULL
SDS-sample	NULL
buffer	NULL
,	NULL
antigen-antibody	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-PAGE	NULL
that	NULL
was	NULL
vacuum	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
.	NULL

No	NULL
protein	NULL
was	NULL
immunoprecipitated	NULL
by	NULL
the	NULL
control	NULL
IgG	NULL
in	NULL
FN-treated	NULL
cells	NULL
(	NULL
FN*	NULL
)	NULL
.	NULL

When	NULL
cells	NULL
exposed	NULL
to	NULL
FN	NULL
alone	NULL
(	NULL
FN	NULL
)	NULL
were	NULL
examined	NULL
,	NULL
no	NULL
IL-1B	NULL
protein	NULL
was	NULL
found	NULL
in	NULL
the	NULL
cell	NULL
extract	NULL
,	NULL
whereas	NULL
the	NULL
IL-1B	NULL
precursor	NULL
protein	NULL
(	NULL
31000	NULL
MW	NULL
)	NULL
and	NULL
especially	NULL
the	NULL
active	NULL
protein	NULL
(	NULL
17000	NULL
MW	NULL
)	NULL
were	NULL
found	NULL
in	NULL
the	NULL
supernatant	NULL
.	NULL

In	NULL
cells	NULL
pretreated	NULL
with	NULL
St	NULL
prior	NULL
to	NULL
exposure	NULL
to	NULL
FN	NULL
(	NULL
FN	NULL
St	NULL
)	NULL
,	NULL
increased	NULL
quantities	NULL
of	NULL
IL-1fB	NULL
precursor	NULL
protein	NULL
were	NULL
found	NULL
in	NULL
the	NULL
cell	NULL
extract	NULL
,	NULL
but	NULL
no	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
the	NULL
supernatant	NULL
.	NULL

In	NULL
parallel	NULL
experiments	NULL
,	NULL
cells	NULL
pretreated	NULL
with	NULL
CC	NULL
prior	NULL
to	NULL
exposure	NULL
to	NULL
FN	NULL
(	NULL
FN	NULL
CC	NULL
)	NULL
,	NULL
showed	NULL
no	NULL
IL-1fB	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
cell	NULL
extracts	NULL
or	NULL
supernatants	NULL
.	NULL

Staurosporine	NULL
treatment	NULL
prior	NULL
to	NULL
FN	NULL
exposure	NULL
resulted	NULL
in	NULL
accumulation	NULL
of	NULL
the	NULL
intracellular	NULL
IL-1	NULL
$	NULL
B	NULL
precursor	NULL
protein	NULL
,	NULL
but	NULL
no	NULL
detectable	NULL
levels	NULL
of	NULL
precursor	NULL
or	NULL
active	NULL
IL-1	NULL
were	NULL
released	NULL
into	NULL
the	NULL
extracellular	NULL
medium	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
St	NULL
,	NULL
CC-treated	NULL
cells	NULL
did	NULL
not	NULL
show	NULL
intracellular	NULL
or	NULL
extracellular	NULL
IL-1	NULL
protein	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
above	NULL
results	NULL
suggest	NULL
that	NULL
St	NULL
and	NULL
CC	NULL
inhibit	NULL
the	NULL
FN-induced	NULL
IL-1	NULL
B	NULL
response	NULL
by	NULL
different	NULL
mechanisms	NULL
of	NULL
action	NULL
.	NULL

In	NULL
order	NULL
to	NULL
investigate	NULL
this	NULL
in	NULL
more	NULL
detail	NULL
,	NULL
we	NULL
turned	NULL
to	NULL
monocytic	NULL
U937	NULL
cells	NULL
since	NULL
they	NULL
have	NULL
the	NULL
intracellular	NULL
machinery	NULL
necessary	NULL
for	NULL
production	NULL
of	NULL
in	NULL
response	NULL
to	NULL
FN	NULL
(	NULL
23	NULL
;	NULL
Roman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
CC	NULL
and	NULL
St	NULL
on	NULL
FN	NULL
induction	NULL
of	NULL
IL-16	NULL
mRNA	NULL
in	NULL
U937	NULL
cells	NULL
FN	NULL
induced	NULL
an	NULL
increase	NULL
in	NULL
IL-1B	NULL
mRNA	NULL
accumulation	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
with	NULL
an	NULL
increase	NULL
of	NULL
almost	NULL
20	NULL
%	NULL
with	NULL
100	NULL
ug/ml	NULL
FN	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
,	NULL
lane	NULL
2	NULL
;	NULL
Fig	NULL
.	NULL

3¢	NULL
,	NULL
FN/100	NULL
)	NULL
and	NULL
53	NULL
%	NULL
with	NULL
200	NULL
ug/ml	NULL
FN	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
,	NULL
lane	NULL
3	NULL
;	NULL
Fig	NULL
.	NULL

3¢c	NULL
,	NULL
FN/200	NULL
)	NULL
when	NULL
compared	NULL
with	NULL
untreated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Activated	NULL
CC	NULL
©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
95	NULL
,	NULL
264-271	NULL
alone	NULL
decreased	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
,	NULL
lane	NULL
4	NULL
;	NULL
Fig	NULL
.	NULL

3¢c	NULL
,	NULL
CC*	NULL
)	NULL
.	NULL

It	NULL
was	NULL
also	NULL
able	NULL
to	NULL
block	NULL
the	NULL
FN-induced	NULL
accumulation	NULL
of	NULL
IL-1B	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
,	NULL
lane	NULL
6	NULL
;	NULL
Fig	NULL
.	NULL

3¢c	NULL
,	NULL
FN+CC*	NULL
)	NULL
.	NULL

Inactive	NULL
CC	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
was	NULL
not	NULL
able	NULL
to	NULL
inhibit	NULL
the	NULL
FN-induced	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
,	NULL
lane	NULL
5	NULL
;	NULL
Fig	NULL
.	NULL

3¢c	NULL
,	NULL
FN	NULL
+	NULL
CC	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
and	NULL
consistent	NULL
with	NULL
the	NULL
PBMC	NULL
immunoprecipitation	NULL
data	NULL
,	NULL
IL-1B	NULL
mRNA	NULL
accumulation	NULL
in	NULL
response	NULL
to	NULL
FN	NULL
took	NULL
place	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
St	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
,	NULL
lanes	NULL
7,8	NULL
;	NULL
Fig	NULL
.	NULL

3¢c	NULL
,	NULL
FN	NULL
+	NULL
St	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
accumulation	NULL
of	NULL
IL-1	NULL
mRNA	NULL
occurred	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
St	NULL
alone	NULL
,	NULL
suggesting	NULL
a	NULL
direct	NULL
stimulatory	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
,	NULL
lane	NULL
7	NULL
;	NULL
Fig	NULL
.	NULL

3¢	NULL
,	NULL
St	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
GAPDH	NULL
gene	NULL
was	NULL
used	NULL
to	NULL
normalize	NULL
for	NULL
mRNA	NULL
sample	NULL
loading	NULL
as	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
(	NULL
b	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
CC	NULL
and	NULL
St	NULL
on	NULL
IL-1f	NULL
gene	NULL
transcription	NULL
in	NULL
transfected	NULL
U937	NULL
cells	NULL
To	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
CC	NULL
and	NULL
St	NULL
on	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IL-1	NULL
$	NULL
B	NULL
gene	NULL
induced	NULL
by	NULL
FN	NULL
,	NULL
U937	NULL
seconds	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
full-length	NULL
human	NULL
IL-1B	NULL
promoter	NULL
,	NULL
pIL-1	NULL
(	NULL
4:0	NULL
kb	NULL
)	NULL
,	NULL
connected	NULL
to	NULL
a	NULL
luciferase	NULL
(	NULL
LUC	NULL
)	NULL
reporter	NULL
gene	NULL
,	NULL
pIL-1	NULL
(	NULL
4-0	NULL
kb	NULL
)	NULL
268	NULL
J.	NULL
Ritzenthaler	NULL
&	NULL
J.	NULL
Roman	NULL
%	NULL
control	NULL
IL-1B	NULL
mRNA	NULL
(	NULL
relative	NULL
densitometry	NULL
units	NULL
)	NULL
FN	NULL
FN	NULL
CC*	NULL
FN	NULL
FN	NULL
St	NULL
FN	NULL
100	NULL
200	NULL
+	NULL
+	NULL
+	NULL
CC	NULL
CC®	NULL
St	NULL
Figure	NULL
3	NULL
.	NULL

Effects	NULL
of	NULL
PKC	NULL
inhibitors	NULL
on	NULL
FN-induced	NULL
IL-1B	NULL
mRNA	NULL
accumulation	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
Staurosporine	NULL
(	NULL
St	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
activated	NULL
(	NULL
CC*	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
or	NULL
inactivated	NULL
(	NULL
CC	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
Calphostin	NULL
C	NULL
at	NULL
1	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
a	NULL
2	NULL
hr	NULL
stimulation	NULL
with	NULL
(	NULL
100	NULL
ug/ml	NULL
,	NULL
lane	NULL
2	NULL
;	NULL
200	NULL
ug/ml	NULL
;	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
or	NULL
without	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
soluble	NULL
LPS-free	NULL
FN	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
,	NULL
electroph-oresed	NULL
in	NULL
a	NULL
12	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
22	NULL
M	NULL
formaldehyde	NULL
and	NULL
semi-dry	NULL
transferred	NULL
onto	NULL
nylon	NULL
membrane	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
1	NULL
mA/cm	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
radio-labelled	NULL
IL-1B	NULL
cDNA	NULL
at	NULL
1-10	NULL
x	NULL
10°	NULL
c.p.m./ml	NULL
at	NULL
42°	NULL
in	NULL
a	NULL
hybridization	NULL
oven	NULL
for	NULL
24	NULL
hr	NULL
,	NULL
washed	NULL
with	NULL
sodium	NULL
chloride	NULL
sodium	NULL
citrate	NULL
solution	NULL
(	NULL
SSC	NULL
)	NULL
at	NULL
55°	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
for	NULL
24	NULL
hr	NULL
.	NULL

(	NULL
b	NULL
)	NULL
For	NULL
control	NULL
,	NULL
membranes	NULL
were	NULL
probed	NULL
with	NULL
a	NULL
radio-labelled	NULL
GAPDH	NULL
probe	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Densitometric	NULL
scanning	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
laser	NULL
densitometer	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
expression	NULL
of	NULL
IL-1B	NULL
mRNA	NULL
is	NULL
depicted	NULL
as	NULL
the	NULL
ratio	NULL
between	NULL
the	NULL
relative	NULL
densitometric	NULL
units	NULL
obtained	NULL
from	NULL
Northern	NULL
blots	NULL
for	NULL
IL-1	NULL
and	NULL
GAPDH	NULL
.	NULL

Note	NULL
that	NULL
U937s	NULL
exposed	NULL
to	NULL
FN	NULL
expressed	NULL
more	NULL
IL-1B	NULL
mRNA	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
control	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
dose	NULL
dependent	NULL
with	NULL
higher	NULL
expression	NULL
seen	NULL
with	NULL
200	NULL
ug/ml	NULL
of	NULL
FN	NULL
(	NULL
FN	NULL
200	NULL
)	NULL
.	NULL

Activated	NULL
Calphostin	NULL
C	NULL
(	NULL
CC*	NULL
)	NULL
decreased	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
IL-1B	NULL
mRNA	NULL
and	NULL
suppressed	NULL
the	NULL
FN	NULL
induction	NULL
of	NULL
the	NULL
message	NULL
(	NULL
FN+CC*	NULL
)	NULL
,	NULL
whereas	NULL
inactive	NULL
Calphostin	NULL
C	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
FN+CC	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
IL-1B	NULL
message	NULL
was	NULL
seen	NULL
when	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
St	NULL
alone	NULL
and	NULL
this	NULL
agent	NULL
did	NULL
not	NULL
block	NULL
the	NULL
stimulatory	NULL
effect	NULL
of	NULL
FN	NULL
(	NULL
FN	NULL
+	NULL
St	NULL
)	NULL
.	NULL

LUC	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
FN	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
pIL-1	NULL
(	NULL
4-0	NULL
kb	NULL
)	NULL
LUC	NULL
in	NULL
transfected	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
FN	NULL
)	NULL
when	NULL
compared	NULL
with	NULL
untreated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
Control	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
abolished	NULL
by	NULL
pretreatment	NULL
with	NULL
activated	NULL
CC	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
FN+CC*	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
pretreatment	NULL
with	NULL
inactivated	NULL
CC	NULL
i	NULL
be	NULL
1	NULL
pIL-1	NULL
(	NULL
4-0	NULL
)	NULL
LUC	NULL
expression	NULL
1	NULL
(	NULL
relative	NULL
luciferase	NULL
activity	NULL
)	NULL
Control	NULL
CC*	NULL
FN	NULL
FN	NULL
FN	NULL
St	NULL
FN	NULL
CC	NULL
CC*	NULL
St	NULL
Figure	NULL
4	NULL
.	NULL

Effects	NULL
of	NULL
PKC	NULL
inhibitors	NULL
on	NULL
IL-1	NULL
gene	NULL
transcription	NULL
.	NULL

U937	NULL
cells	NULL
(	NULL
48	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
were	NULL
electroporated	NULL
with	NULL
40	NULL
ug	NULL
pIL-1	NULL
(	NULL
4:0	NULL
kb	NULL
)	NULL
LUC	NULL
plasmid	NULL
DNA	NULL
,	NULL
20	NULL
ug	NULL
B-galactosidase	NULL
plasmid	NULL
DNA	NULL
,	NULL
allowed	NULL
to	NULL
recover	NULL
for	NULL
1	NULL
hr	NULL
in	NULL
RPMI-1640	NULL
,	NULL
pooled	NULL
,	NULL
aliquoted	NULL
into	NULL
24-well	NULL
plates	NULL
,	NULL
and	NULL
treated	NULL
for	NULL
16	NULL
hr	NULL
at	NULL
37°	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
with	NULL
or	NULL
without	NULL
100	NULL
ug/ml	NULL
soluble	NULL
LPS-free	NULL
FN	NULL
(	NULL
FN	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
activated	NULL
(	NULL
CC*	NULL
)	NULL
or	NULL
inactivated	NULL
(	NULL
CC	NULL
)	NULL
Calphostin	NULL
C	NULL
or	NULL
Staurosporine	NULL
(	NULL
St	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
100	NULL
ul	NULL
cell	NULL
lysis	NULL
buffer	NULL
and	NULL
an	NULL
aliquot	NULL
(	NULL
20	NULL
ul	NULL
)	NULL
was	NULL
added	NULL
to	NULL
50	NULL
ul	NULL
luciferase	NULL
assay	NULL
reagent	NULL
and	NULL
tested	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
a	NULL
Dynatech	NULL
ML	NULL
3000	NULL
microtitre	NULL
plate	NULL
luminometer	NULL
.	NULL

Results	NULL
represents	NULL
the	NULL
ratio	NULL
of	NULL
stimulated	NULL
IL-1B	NULL
gene	NULL
expression	NULL
over	NULL
unstimulated	NULL
controls	NULL
and	NULL
recorded	NULL
as	NULL
relative	NULL
luciferase	NULL
units	NULL
and	NULL
standardized	NULL
for	NULL
transfection	NULL
efficiency	NULL
using	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Samples	NULL
were	NULL
normalized	NULL
to	NULL
total	NULL
protein	NULL
measured	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
using	NULL
Coomassie	NULL
blue	NULL
G-250	NULL
.	NULL

Note	NULL
that	NULL
cells	NULL
stimulated	NULL
with	NULL
100	NULL
ug/ml	NULL
of	NULL
FN	NULL
(	NULL
FN	NULL
)	NULL
showed	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
when	NULL
compared	NULL
with	NULL
control	NULL
.	NULL

Activated	NULL
CC	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
untreated	NULL
cells	NULL
(	NULL
CC*	NULL
)	NULL
but	NULL
inhibited	NULL
the	NULL
FN-induced	NULL
response	NULL
(	NULL
FN+CC*	NULL
)	NULL
.	NULL

Inactivated	NULL
CC	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
stimulatory	NULL
effect	NULL
of	NULL
FN	NULL
(	NULL
FN+CC	NULL
)	NULL
.	NULL

Staurosporine	NULL
alone	NULL
induced	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
St	NULL
)	NULL
and	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
FN-induced	NULL
response	NULL
(	NULL
FN	NULL
+	NULL
St	NULL
)	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
FN+CC	NULL
)	NULL
or	NULL
by	NULL
St	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
FN+St	NULL
)	NULL
.	NULL

Staurosporine	NULL
alone	NULL
induced	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IL-1f	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
St	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
CC	NULL
and	NULL
St	NULL
on	NULL
nuclear	NULL
translocation	NULL
of	NULL
AP-1	NULL
We	NULL
have	NULL
observed	NULL
that	NULL
FN	NULL
induction	NULL
of	NULL
IL-1	NULL
gene	NULL
transcription	NULL
is	NULL
associated	NULL
with	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
trans-acting	NULL
factor	NULL
AP-1	NULL
(	NULL
Roman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
predicted	NULL
that	NULL
its	NULL
effects	NULL
might	NULL
be	NULL
due	NULL
to	NULL
inhibition	NULL
of	NULL
AP-1	NULL
nuclear	NULL
translocation	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
DNA	NULL
electrophoresis	NULL
mobility	NULL
gel	NULL
shift	NULL
assay	NULL
shows	NULL
very	NULL
little	NULL
binding	NULL
of	NULL
nuclear	NULL
protein	NULL
to	NULL
radio-labelled	NULL
AP-1	NULL
consensus	NULL
oligonucleotide	NULL
in	NULL
untreated	NULL
U937	NULL
cells	NULL
(	NULL
C	NULL
;	NULL
Fig	NULL
.	NULL

Sa	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
active	NULL
(	NULL
CC*	NULL
;	NULL
Fig	NULL
.	NULL

5a	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
inactive	NULL
CC	NULL
(	NULL
CC	NULL
;	NULL
Fig	NULL
.	NULL

Sa	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
increased	NULL
binding	NULL
was	NULL
detected	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
FN	NULL
(	NULL
FN	NULL
;	NULL
Fig	NULL
.	NULL

5a	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
prevented	NULL
by	NULL
activated	NULL
CC	NULL
(	NULL
FN/CC*	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5a	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
but	NULL
not	NULL
inactivated	NULL
CC	NULL
(	NULL
FN/CC	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5a	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
St	NULL
did	NULL
not	NULL
inhibit	NULL
nuclear	NULL
binding	NULL
to	NULL
radio-labelled	NULL
AP-1	NULL
consensus	NULL
oligonucleotide	NULL
;	NULL
instead	NULL
,	NULL
it	NULL
induced	NULL
AP-1	NULL
translocation	NULL
into	NULL
the	NULL
nucleus	NULL
with	NULL
(	NULL
FN/St	NULL
;	NULL
Fig	NULL
.	NULL

5a	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
or	NULL
without	NULL
(	NULL
St	NULL
;	NULL
Fig	NULL
.	NULL

5a	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
exposure	NULL
to	NULL
FN	NULL
.	NULL

Bound	NULL
radio-labelled	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
B	NULL
)	NULL
were	NULL
quantified	NULL
by	NULL
scintillation	NULL
counter	NULL
and	NULL
the	NULL
data	NULL
is	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
(	NULL
b	NULL
)	NULL
.	NULL

©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
95	NULL
,	NULL
264-271	NULL
Protein	NULL
kinase	NULL
C	NULL
and	NULL
fibronectin-induced	NULL
IL-1	NULL
$	NULL
269	NULL
FN	NULL
FN	NULL
FN	NULL
FN	NULL
P	NULL
C	NULL
CC	NULL
CC	NULL
St	NULL
St	NULL
CC	NULL
CC*	NULL
B	NULL
-	NULL
>	NULL
ed	NULL
bas	NULL
I	NULL
“	NULL
Hugh	NULL
!	NULL

“	NULL
(	NULL
b	NULL
)	NULL
50	NULL
40	NULL
a	NULL
30	NULL
[	NULL
6	NULL
]	NULL
20	NULL
10	NULL
0	NULL
Control	NULL
CC	NULL
CC*	NULL
FN	NULL
FN	NULL
FN	NULL
St	NULL
FN	NULL
CC	NULL
CC*	NULL
St	NULL
Figure	NULL
5	NULL
.	NULL

Effects	NULL
of	NULL
PKC	NULL
inhibitors	NULL
on	NULL
AP-1	NULL
nuclear	NULL
translocation	NULL
.	NULL

(	NULL
a	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
16	NULL
hr	NULL
with	NULL
or	NULL
without	NULL
100	NULL
ug/ml	NULL
soluble	NULL
LPS-free	NULL
FN	NULL
(	NULL
FN	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
activated	NULL
(	NULL
CC*	NULL
)	NULL
or	NULL
inactivated	NULL
(	NULL
CC	NULL
)	NULL
Calphostin	NULL
C	NULL
or	NULL
Staurosporine	NULL
(	NULL
St	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
with	NULL
ice-cold	NULL
PBS	NULL
,	NULL
and	NULL
nuclear	NULL
binding	NULL
proteins	NULL
were	NULL
extracted	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
using	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
reagent	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Nuclear	NULL
protein	NULL
(	NULL
2	NULL
5	NULL
ug	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
radio-labelled	NULL
consensus	NULL
double-stranded	NULL
AP-1	NULL
oligonucleotide	NULL
(	NULL
3-	NULL
600000	NULL
c.p.m./ng	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
tem-perature	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
6	NULL
%	NULL
native	NULL
poly-acrylamide	NULL
gels	NULL
that	NULL
were	NULL
fixed	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
.	NULL
'	NULL

B	NULL
``	NULL
represents	NULL
the	NULL
bound	NULL
DNA-protein	NULL
complexes	NULL
:	NULL
°F	NULL
``	NULL
represents	NULL
the	NULL
radio-labelled	NULL
consensus	NULL
double-stranded	NULL
AP-1	NULL
oligonucleotide	NULL
.	NULL

Lane	NULL
1	NULL
:	NULL
radio-labelled	NULL
consensus	NULL
double-stranded	NULL
AP-1_	NULL
oligonucleotide	NULL
alone	NULL
.	NULL

Lane	NULL
2	NULL
:	NULL
control	NULL
unstimulated	NULL
U937	NULL
cells	NULL
.	NULL

Lane	NULL
3	NULL
:	NULL
cells	NULL
treated	NULL
with	NULL
inactivated	NULL
CC	NULL
.	NULL

Lane	NULL
4	NULL
:	NULL
cells	NULL
treated	NULL
with	NULL
activated	NULL
CC	NULL
alone	NULL
.	NULL

Lane	NULL
5	NULL
:	NULL
cells	NULL
treated	NULL
with	NULL
100	NULL
ug/ml	NULL
soluble	NULL
LPS-free	NULL
FN	NULL
.	NULL

Lane	NULL
6	NULL
:	NULL
cells	NULL
treated	NULL
with	NULL
inactive	NULL
CC	NULL
and	NULL
100	NULL
ug/ml	NULL
soluble	NULL
LPS-free	NULL
FN	NULL
.	NULL

Lane	NULL
7	NULL
:	NULL
cells	NULL
treated	NULL
with	NULL
activated	NULL
CC	NULL
and	NULL
100	NULL
ug/ml	NULL
soluble	NULL
LPS-free	NULL
FN	NULL
.	NULL

Lane	NULL
8	NULL
:	NULL
cells	NULL
treated	NULL
with	NULL
St	NULL
alone	NULL
.	NULL

Lane	NULL
9	NULL
:	NULL
cells	NULL
treated	NULL
with	NULL
St	NULL
and	NULL
100	NULL
ug/ml	NULL
soluble	NULL
LPS-free	NULL
FN	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Radio-labelled	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
extracted	NULL
from	NULL
gels	NULL
and	NULL
quantitated	NULL
by	NULL
scintillation	NULL
counter	NULL
and	NULL
expressed	NULL
as	NULL
a	NULL
c.p.m	NULL
.	NULL

Note	NULL
that	NULL
untreated	NULL
cells	NULL
contain	NULL
AP-1	NULL
in	NULL
their	NULL
nucleus	NULL
(	NULL
Control	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
AP-1	NULL
increased	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
FN	NULL
(	NULL
FN	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
blocked	NULL
by	NULL
activated	NULL
CC	NULL
(	NULL
FN+CC*	NULL
)	NULL
but	NULL
not	NULL
by	NULL
the	NULL
inactivated	NULL
inhibitor	NULL
(	NULL
FN	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
St	NULL
alone	NULL
induced	NULL
AP-1	NULL
translocation	NULL
(	NULL
St	NULL
)	NULL
and	NULL
it	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
FN-induced	NULL
response	NULL
(	NULL
FN	NULL
+	NULL
St	NULL
)	NULL
.	NULL

€	NULL
1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
95	NULL
,	NULL
264	NULL
271	NULL
DISCUSSION	NULL
The	NULL
role	NULL
of	NULL
PKC	NULL
in	NULL
IL-1B	NULL
production	NULL
is	NULL
well	NULL
established	NULL
:	NULL
'	NULL
``	NULL
``	NULL
*	NULL
however	NULL
,	NULL
the	NULL
relevance	NULL
of	NULL
this	NULL
pathway	NULL
in	NULL
matrix-induced	NULL
IL-1B	NULL
expression	NULL
has	NULL
only	NULL
recently	NULL
been	NULL
explored	NULL
(	NULL
refs	NULL
5	NULL
,	NULL
6	NULL
,	NULL
25	NULL
,	NULL
26	NULL
;	NULL
for	NULL
review	NULL
see	NULL
11	NULL
)	NULL
.	NULL

Studies	NULL
demonstrating	NULL
the	NULL
activation	NULL
of	NULL
PKC	NULL
in	NULL
monocytic	NULL
cells	NULL
treated	NULL
with	NULL
FN	NULL
,	NULL
*°	NULL
and	NULL
the	NULL
inhibition	NULL
of	NULL
IL-1B	NULL
(	NULL
as	NULL
determined	NULL
by	NULL
measuring	NULL
bioactivity	NULL
)	NULL
in	NULL
cells	NULL
pretreated	NULL
with	NULL
inhibitors	NULL
of	NULL
PKC	NULL
``	NULL
did	NULL
not	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
reagents	NULL
on	NULL
gene	NULL
expression	NULL
or	NULL
protein	NULL
synthesis	NULL
and	NULL
processing	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
exact	NULL
step	NULL
(	NULL
s	NULL
)	NULL
at	NULL
which	NULL
PKC	NULL
acts	NULL
to	NULL
mediate	NULL
the	NULL
FN-induced	NULL
IL-1	NULL
$	NULL
response	NULL
remains	NULL
unclear	NULL
.	NULL

Herein	NULL
,	NULL
it	NULL
is	NULL
shown	NULL
that	NULL
CC	NULL
inhibits	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IL-1B	NULL
gene	NULL
in	NULL
cells	NULL
exposed	NULL
to	NULL
FN	NULL
.	NULL

Inhibition	NULL
of	NULL
gene	NULL
transcription	NULL
by	NULL
CC	NULL
explains	NULL
the	NULL
decrease	NULL
observed	NULL
in	NULL
the	NULL
accumulation	NULL
of	NULL
endogenous	NULL
IL-1B	NULL
mRNA	NULL
and	NULL
the	NULL
absence	NULL
of	NULL
IL-1	NULL
B	NULL
protein	NULL
observed	NULL
in	NULL
PBMCs	NULL
pretreated	NULL
with	NULL
CC	NULL
prior	NULL
to	NULL
exposure	NULL
to	NULL
FN	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
recognized	NULL
specificity	NULL
of	NULL
CC	NULL
for	NULL
PKC	NULL
,	NULL
the	NULL
data	NULL
also	NULL
indicate	NULL
that	NULL
PKC	NULL
acts	NULL
to	NULL
stimulate	NULL
transcription	NULL
of	NULL
the	NULL
IL-1	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
FN	NULL
.	NULL

Although	NULL
the	NULL
literature	NULL
contains	NULL
little	NULL
information	NULL
regarding	NULL
IL-1B	NULL
gene	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
FN	NULL
,	NULL
our	NULL
findings	NULL
regarding	NULL
PKC	NULL
and	NULL
IL-1	NULL
B	NULL
are	NULL
in	NULL
line	NULL
with	NULL
those	NULL
of	NULL
others	NULL
that	NULL
have	NULL
stimulated	NULL
cells	NULL
with	NULL
agents	NULL
other	NULL
than	NULL
FN	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Shapira	NULL
and	NULL
associates	NULL
(	NULL
1994	NULL
)	NULL
stimulated	NULL
monocytic	NULL
cells	NULL
with	NULL
LPS	NULL
and	NULL
found	NULL
that	NULL
H-7	NULL
,	NULL
a	NULL
PKC	NULL
and	NULL
cyclic	NULL
nucleotide-dependent	NULL
protein	NULL
kinase	NULL
inhibitor	NULL
,	NULL
inhibited	NULL
LPS-induced	NULL
IL-1	NULL
production	NULL
and	NULL
concluded	NULL
that	NULL
LPS-induction	NULL
of	NULL
IL-1B	NULL
expression	NULL
requires	NULL
activation	NULL
of	NULL
PKC	NULL
upstream	NULL
to	NULL
gene	NULL
transcription	NULL
.	NULL

*	NULL
``	NULL
'	NULL
Data	NULL
presented	NULL
herein	NULL
suggest	NULL
that	NULL
PKC	NULL
induction	NULL
by	NULL
FN	NULL
is	NULL
followed	NULL
by	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
AP-1	NULL
.	NULL

a	NULL
trans-acting	NULL
factor	NULL
known	NULL
to	NULL
induce	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IL-1B	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
PKC	NULL
could	NULL
mediate	NULL
the	NULL
FN-induced	NULL
IL-1B	NULL
response	NULL
via	NULL
other	NULL
mechanisms	NULL
including	NULL
enhanced	NULL
phosphorylation	NULL
of	NULL
ppl25fak	NULL
in	NULL
CHO	NULL
cells	NULL
,	NULL
a	NULL
tyrosine	NULL
kinase	NULL
that	NULL
may	NULL
promote	NULL
signal	NULL
transduction	NULL
.	NULL
``	NULL

''	NULL
or	NULL
phosphorylation	NULL
of	NULL
DNA	NULL
methyltransferase	NULL
,	NULL
an	NULL
enzyme	NULL
that	NULL
acts	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
alters	NULL
gene	NULL
expression	NULL
by	NULL
changing	NULL
DNA	NULL
methylation	NULL
patterns	NULL
.	NULL

``	NULL
°	NULL
It	NULL
is	NULL
also	NULL
conceivable	NULL
that	NULL
PKC	NULL
acts	NULL
on	NULL
nuclear	NULL
proteins	NULL
other	NULL
than	NULL
AP-1	NULL
(	NULL
e.g	NULL
.	NULL

NF-BA	NULL
)	NULL
.	NULL

``	NULL
°	NULL
In	NULL
contrast	NULL
to	NULL
the	NULL
studies	NULL
with	NULL
CC	NULL
,	NULL
interpretations	NULL
based	NULL
on	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
St	NULL
are	NULL
difficult	NULL
because	NULL
of	NULL
studies	NULL
showing	NULL
its	NULL
ability	NULL
to	NULL
inhibit	NULL
PKC	NULL
activation	NULL
by	NULL
non-specific	NULL
mechanisms	NULL
and	NULL
its	NULL
demonstrated	NULL
ability	NULL
to	NULL
affect	NULL
other	NULL
kinases	NULL
such	NULL
as	NULL
PKA	NULL
.	NULL

'*	NULL
``	NULL
This	NULL
last	NULL
mechanism	NULL
,	NULL
however	NULL
,	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
relevant	NULL
to	NULL
the	NULL
FN-induced	NULL
IL-1B	NULL
response	NULL
as	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
FN	NULL
does	NULL
not	NULL
induce	NULL
cAMP	NULL
in	NULL
human	NULL
monocytes	NULL
,	NULL
and	NULL
that	NULL
the	NULL
protein	NULL
kinase	NULL
A	NULL
inhibitor	NULL
H	NULL
89	NULL
does	NULL
not	NULL
block	NULL
its	NULL
stimulatory	NULL
effect	NULL
.	NULL
``	NULL

In	NULL
our	NULL
studies	NULL
,	NULL
St	NULL
did	NULL
not	NULL
inhibit	NULL
transcription	NULL
of	NULL
the	NULL
IL-1B	NULL
gene	NULL
in	NULL
transfected	NULL
U937	NULL
cells	NULL
or	NULL
the	NULL
accumulation	NULL
of	NULL
endogenous	NULL
IL-1B	NULL
mRNA	NULL
;	NULL
nor	NULL
did	NULL
it	NULL
inhibit	NULL
IL-1B	NULL
protein	NULL
synthesis	NULL
in	NULL
PBMCs	NULL
.	NULL

Instead	NULL
,	NULL
St	NULL
inhibited	NULL
the	NULL
secretion	NULL
of	NULL
newly	NULL
synthesized	NULL
IL-1B	NULL
protein	NULL
as	NULL
demonstrated	NULL
in	NULL
PBMCs	NULL
.	NULL

These	NULL
conclusions	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
by	NULL
Bakouche	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
who	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
St	NULL
on	NULL
induction	NULL
of	NULL
IL-1B	NULL
production	NULL
by	NULL
LPS	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL
``	NULL

'	NULL
These	NULL
investigators	NULL
demonstrated	NULL
that	NULL
free	NULL
LPS	NULL
induced	NULL
translocation	NULL
of	NULL
PKC	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
that	NULL
this	NULL
was	NULL
followed	NULL
by	NULL
production	NULL
and	NULL
secretion	NULL
of	NULL
IL-lx	NULL
and	NULL
IL-1B	NULL
.	NULL

The	NULL
270	NULL
stimulatory	NULL
effect	NULL
of	NULL
LPS	NULL
was	NULL
blocked	NULL
by	NULL
co-treatment	NULL
with	NULL
St	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
free	NULL
LPS	NULL
,	NULL
stimulation	NULL
of	NULL
cells	NULL
with	NULL
LPS	NULL
presented	NULL
in	NULL
multi-lamelar	NULL
vesicles	NULL
did	NULL
not	NULL
induce	NULL
PKC	NULL
translocation	NULL
or	NULL
IL-1	NULL
secretion	NULL
,	NULL
but	NULL
did	NULL
induce	NULL
its	NULL
production	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
IL-1	NULL
production	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
St	NULL
.	NULL

The	NULL
latter	NULL
observation	NULL
led	NULL
the	NULL
authors	NULL
to	NULL
conclude	NULL
that	NULL
activation	NULL
of	NULL
PKC	NULL
is	NULL
necessary	NULL
for	NULL
LPS-induced	NULL
secretion	NULL
of	NULL
IL-1	NULL
,	NULL
but	NULL
not	NULL
its	NULL
production	NULL
.	NULL

Using	NULL
northern	NULL
blot	NULL
analysis	NULL
,	NULL
Geng	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
found	NULL
that	NULL
herbimycin	NULL
A	NULL
blocked	NULL
LPS	NULL
induction	NULL
of	NULL
IL-1B	NULL
mRNA	NULL
,	NULL
whereas	NULL
St	NULL
did	NULL
not	NULL
,	NULL
again	NULL
suggesting	NULL
that	NULL
IL-1B	NULL
production	NULL
was	NULL
not	NULL
altered	NULL
by	NULL
St.	NULL
``	NULL
Differences	NULL
in	NULL
the	NULL
effects	NULL
of	NULL
CC	NULL
and	NULL
St	NULL
are	NULL
likely	NULL
explained	NULL
by	NULL
the	NULL
differential	NULL
effects	NULL
of	NULL
these	NULL
agents	NULL
on	NULL
proteins	NULL
other	NULL
than	NULL
PKC	NULL
.	NULL

St	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
translocation	NULL
of	NULL
PKC	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
abolish	NULL
its	NULL
activity	NULL
.	NULL
``	NULL

''	NULL
Thus	NULL
,	NULL
its	NULL
activity	NULL
as	NULL
a	NULL
PKC	NULL
inhibitor	NULL
is	NULL
not	NULL
ques-tioned	NULL
.	NULL

However	NULL
,	NULL
because	NULL
of	NULL
its	NULL
non-specific	NULL
effects	NULL
,	NULL
it	NULL
is	NULL
also	NULL
likely	NULL
to	NULL
affect	NULL
various	NULL
other	NULL
processes	NULL
.	NULL

Herein	NULL
,	NULL
we	NULL
show	NULL
that	NULL
St	NULL
can	NULL
directly	NULL
cause	NULL
nuclear	NULL
translocation	NULL
of	NULL
AP-1	NULL
,	NULL
which	NULL
is	NULL
followed	NULL
by	NULL
IL-1B	NULL
gene	NULL
transcription	NULL
,	NULL
mRNA	NULL
accumulation	NULL
,	NULL
and	NULL
protein	NULL
synthesis	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
St	NULL
inhibits	NULL
the	NULL
secretion	NULL
of	NULL
IL-1	NULL
B	NULL
protein	NULL
remain	NULL
unknown	NULL
.	NULL

Secretion	NULL
of	NULL
IL-1fB	NULL
does	NULL
not	NULL
follow	NULL
the	NULL
normal	NULL
exocytic	NULL
pathway	NULL
.	NULL
``	NULL

The	NULL
rate	NULL
of	NULL
IL-1B	NULL
secretion	NULL
appears	NULL
affected	NULL
by	NULL
the	NULL
intracellular	NULL
calcium	NULL
concentration	NULL
,	NULL
**	NULL
and	NULL
proper	NULL
folding	NULL
of	NULL
the	NULL
mature	NULL
protein	NULL
.	NULL
``	NULL

''	NULL
Sequences	NULL
present	NULL
within	NULL
the	NULL
precursor	NULL
molecule	NULL
may	NULL
prevent	NULL
secretion	NULL
by	NULL
affecting	NULL
protein	NULL
conformation	NULL
.	NULL

``	NULL
``	NULL
``	NULL
``	NULL
``	NULL
°	NULL
In	NULL
view	NULL
of	NULL
the	NULL
above	NULL
,	NULL
it	NULL
is	NULL
reasonable	NULL
to	NULL
postulate	NULL
that	NULL
St	NULL
may	NULL
act	NULL
by	NULL
affecting	NULL
the	NULL
processing	NULL
of	NULL
the	NULL
IL-1B	NULL
precursor	NULL
protein	NULL
.	NULL

This	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
immunoprecipitation	NULL
experiments	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
that	NULL
showed	NULL
accumulation	NULL
of	NULL
the	NULL
IL-1B	NULL
precursor	NULL
protein	NULL
,	NULL
but	NULL
not	NULL
the	NULL
active	NULL
form	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
CC	NULL
blocked	NULL
the	NULL
FN-induced	NULL
production	NULL
of	NULL
IL-1B	NULL
by	NULL
preventing	NULL
PKC	NULL
acti-vation	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
inhibited	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
AP-1	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
IL-1	NULL
B	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
St	NULL
induced	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
AP-1	NULL
,	NULL
which	NULL
resulted	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
IL-1B	NULL
gene	NULL
transcription	NULL
,	NULL
mRNA	NULL
accumulation	NULL
,	NULL
and	NULL
IL-1B	NULL
protein	NULL
synthesis	NULL
.	NULL

Although	NULL
St	NULL
induced	NULL
IL-1B	NULL
production	NULL
,	NULL
it	NULL
prevented	NULL
IL-1B	NULL
protein	NULL
secretion	NULL
,	NULL
perhaps	NULL
by	NULL
affecting	NULL
several	NULL
mechanisms	NULL
including	NULL
IL-1	NULL
processing	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
The	NULL
authors	NULL
wish	NULL
to	NULL
thank	NULL
Drs	NULL
John	NULL
Gray	NULL
(	NULL
Glaxo	NULL
)	NULL
and	NULL
Matthew	NULL
W.	NULL
Fenton	NULL
(	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Boston	NULL
University	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
their	NULL
kind	NULL
gift	NULL
of	NULL
IL-1	NULL
genomic	NULL
DNA	NULL
,	NULL
which	NULL
was	NULL
used	NULL
to	NULL
make	NULL
all	NULL
constructs	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
thank	NULL
Dr	NULL
Karen	NULL
Graves	NULL
and	NULL
William	NULL
Schuyler	NULL
for	NULL
their	NULL
assistance	NULL
in	NULL
work	NULL
related	NULL
to	NULL
the	NULL
ELISA	NULL
and	NULL
immunoprecipitation	NULL
analysis	NULL
,	NULL
and	NULL
Susan	NULL
Roser	NULL
for	NULL
the	NULL
Northern	NULL
Blots	NULL
.	NULL

J.R.	NULL
was	NULL
supported	NULL
by	NULL
grant	NULL
no	NULL
.	NULL

NLS1639	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

DinarELLO	NULL
C.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
The	NULL
interleukin-1	NULL
family	NULL
:	NULL
10	NULL
years	NULL
of	NULL
discovery	NULL
.	NULL

FASEB	NULL
J	NULL
8	NULL
,	NULL
1314	NULL
.	NULL

2	NULL
.	NULL

Cannon	NULL
J.G	NULL
.	NULL

,	NULL
Tompkins	NULL
R.G	NULL
.	NULL

,	NULL
Gerranp	NULL
R.G	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Circulating	NULL
interleukin-1	NULL
beta	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
in	NULL
septic	NULL
shock	NULL
and	NULL
experimental	NULL
endotoxin	NULL
fever	NULL
.	NULL

J	NULL
Infect	NULL
Dis	NULL
161	NULL
,	NULL
79	NULL
.	NULL

3	NULL
.	NULL

Dunn	NULL
C.J	NULL
.	NULL

,	NULL
Harper	NULL
M.M	NULL
.	NULL

,	NULL
GisBons	NULL
A.J	NULL
.	NULL

,	NULL
State	NULL
N.D.	NULL
&	NULL
RicHarp	NULL
18	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

J.	NULL
Ritzenthaler	NULL
&	NULL
J.	NULL
Roman	NULL
K.A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Local	NULL
pathological	NULL
responses	NULL
to	NULL
slow-release	NULL
recombi-nant	NULL
interleukin-1	NULL
,	NULL
interleukin-2	NULL
,	NULL
and	NULL
gamma-interferon	NULL
in	NULL
the	NULL
mouse	NULL
,	NULL
and	NULL
their	NULL
relevance	NULL
to	NULL
chronic	NULL
inflammatory	NULL
disease	NULL
.	NULL

Clin	NULL
Sci	NULL
76	NULL
,	NULL
261.	NULL
.	NULL

Herzyx	NULL
D.J	NULL
.	NULL

,	NULL
Auten	NULL
J.N	NULL
.	NULL

,	NULL
MarsHn	NULL
C.B	NULL
.	NULL

&	NULL
Wewsrs	NULL
M.D	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Macrophage	NULL
and	NULL
monocyte	NULL
IL-1B	NULL
regulation	NULL
differs	NULL
at	NULL
multiple	NULL
sites	NULL
.	NULL

J	NULL
Immunol	NULL
149	NULL
,	NULL
3052.	NULL
.	NULL

Graves	NULL
K.L	NULL
.	NULL

&	NULL
Roman	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Fibronectin	NULL
modulates	NULL
expression	NULL
of	NULL
interleukin-1B	NULL
and	NULL
its	NULL
receptor	NULL
antagonist	NULL
in	NULL
human	NULL
mononuclear	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
271	NULL
,	NULL
L61	NULL
.	NULL

.	NULL

Pacirict	NULL
R.	NULL
,	NULL
Basitico	NULL
C.	NULL
,	NULL
Roman	NULL
J.	NULL
,	NULL
ZuttEr	NULL
M.M	NULL
.	NULL

,	NULL
Santoro	NULL
S.A.	NULL
&	NULL
McCracken	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Collagen-induced	NULL
release	NULL
of	NULL
interleukin	NULL
1	NULL
from	NULL
human	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

Potentiation	NULL
by	NULL
fibronectin	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
5B1	NULL
integrin	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
89	NULL
,	NULL
61.	NULL
.	NULL

Roman	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Extracellular	NULL
matrices	NULL
and	NULL
lung	NULL
inflammation	NULL
.	NULL

Immunol	NULL
Res	NULL
15	NULL
,	NULL
163.	NULL
.	NULL

RuostaHt	NULL
:	NULL
E.	NULL
(	NULL
1988	NULL
)	NULL
Fibronectin	NULL
and	NULL
its	NULL
receptors	NULL
.	NULL

Ann	NULL
Rev	NULL
Biochem	NULL
57	NULL
,	NULL
375.	NULL
.	NULL

CLaRK	NULL
EA	NULL
.	NULL

&	NULL
Brugge	NULL
J.S	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Integrins	NULL
and	NULL
signal	NULL
transduc-	NULL
tion	NULL
:	NULL
the	NULL
road	NULL
taken	NULL
.	NULL

Science	NULL
268	NULL
,	NULL
233.	NULL
.	NULL

ParkaMma	NULL
T.	NULL
,	NULL
MatikainEn	NULL
S.	NULL
&	NULL
Hurme	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Tyrosine	NULL
kinase	NULL
activity	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
induced	NULL
expression	NULL
of	NULL
interleukin-16	NULL
gene	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

FEBS	NULL
Lett	NULL
319	NULL
,	NULL
100.	NULL
.	NULL

JuLiANO	NULL
RL	NULL
.	NULL

&	NULL
Haskitt	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Signal	NULL
transduction	NULL
from	NULL
the	NULL
extracellular	NULL
matrix	NULL
.	NULL

J	NULL
Cell	NULL
Bio	NULL
!	NULL

120	NULL
,	NULL
577.	NULL
.	NULL

Pacirict	NULL
R.	NULL
,	NULL
Roman	NULL
J.	NULL
,	NULL
Kimste	NULL
R.	NULL
,	NULL
Civitecu	NULL
R.	NULL
,	NULL
Brownrieto	NULL
C.M	NULL
.	NULL

&	NULL
Bizzarr1	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Ligand	NULL
binding	NULL
to	NULL
monocyte	NULL
«	NULL
581	NULL
integrin	NULL
activates	NULL
the	NULL
«	NULL
281	NULL
receptor	NULL
via	NULL
the	NULL
«	NULL
5	NULL
subunit	NULL
cytoplasmic	NULL
domain	NULL
and	NULL
protein	NULL
kinase	NULL
C.	NULL
J	NULL
Immunol	NULL
153	NULL
,	NULL
2222.	NULL
.	NULL

E.	NULL
,	NULL
Nakano	NULL
H.	NULL
,	NULL
Morimoto	NULL
M.	NULL
&	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Calphostin	NULL
C	NULL
(	NULL
UCN-1028C	NULL
)	NULL
,	NULL
a	NULL
novel	NULL
microbial	NULL
compound	NULL
,	NULL
is	NULL
a	NULL
highly	NULL
potent	NULL
and	NULL
specific	NULL
inhibitor	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
159	NULL
,	NULL
548.	NULL
.	NULL

Lee	NULL
J.C.	NULL
&	NULL
Apams	NULL
J.L	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Inhibitors	NULL
of	NULL
serine/threonine	NULL
kinases	NULL
.	NULL

Current	NULL
Opinion	NULL
Biotechnol	NULL
6	NULL
,	NULL
657.	NULL
.	NULL

Tamaok1	NULL
T.	NULL
,	NULL
Nomoto	NULL
H.	NULL
,	NULL
Isamt	NULL
T.	NULL
,	NULL
Kato	NULL
Y.	NULL
,	NULL
Morimoto	NULL
M.	NULL
&	NULL
Tomita	NULL
F.	NULL
(	NULL
1986	NULL
)	NULL
Staurosporin	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
phospholipid/CA	NULL
**	NULL
dependent	NULL
protein	NULL
kinase	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
1355	NULL
,	NULL
397.	NULL
.	NULL

Roman	NULL
J.	NULL
,	NULL
LackaNnce	NULL
R.M	NULL
.	NULL

,	NULL
BROEKELMANN	NULL
T.J.	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
The	NULL
fibronectin	NULL
receptor	NULL
is	NULL
organized	NULL
by	NULL
extracellular	NULL
matrix	NULL
fibronec-tin	NULL
:	NULL
implications	NULL
for	NULL
oncogenic	NULL
transformation	NULL
and	NULL
for	NULL
cell	NULL
recognition	NULL
of	NULL
fibronectin	NULL
matrices	NULL
.	NULL

J	NULL
Cell	NULL
Bio/	NULL
108	NULL
,	NULL
2529.	NULL
.	NULL

GouLp	NULL
M.C	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Endotoxin	NULL
in	NULL
Vertebrate	NULL
Cell	NULL
Culture	NULL
:	NULL
its	NULL
Measurement	NULL
and	NULL
Significance	NULL
.	NULL

Uses	NULL
:	NULL
and	NULL
Standardization	NULL
of	NULL
Vertebrate	NULL
Cell	NULL
Cultures	NULL
,	NULL
vol	NULL
.	NULL

5	NULL
,	NULL
p.	NULL
125	NULL
.	NULL

Associates	NULL
of	NULL
Cape	NULL
Cod	NULL
,	NULL
Inc.	NULL
,	NULL
Woods	NULL
Hole	NULL
,	NULL
MA	NULL
.	NULL

CHomczynsk1	NULL
P.	NULL
&	NULL
Sacont	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
|	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
Biochem	NULL
162	NULL
,	NULL
156.	NULL
.	NULL

SumBrwk	NULL
J.	NULL
,	NULL
Fritscu	NULL
EF	NULL
.	NULL

&	NULL
Maniatis	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
,	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Springs	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
.	NULL

Braprorp	NULL
M.M	NULL
.	NULL

(	NULL
1976	NULL
)	NULL
A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantification	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
Biochem	NULL
72	NULL
,	NULL
248	NULL
.	NULL

Dignam	NULL
J.D	NULL
.	NULL

,	NULL
Lesovirz	NULL
R.M	NULL
.	NULL

&	NULL
Rogper	NULL
R.G	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nuc	NULL
!	NULL

Acids	NULL
Res	NULL
11	NULL
,	NULL
1475	NULL
.	NULL

RitzentHaLer	NULL
J.D	NULL
.	NULL

,	NULL
GotpstEm	NULL
RH	NULL
.	NULL

,	NULL
Fine	NULL
A	NULL
.	NULL

&	NULL
Smite	NULL
B.D	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Regulation	NULL
of	NULL
the	NULL
«	NULL
1	NULL
(	NULL
I	NULL
)	NULL
collagen	NULL
promoter	NULL
via	NULL
a	NULL
transforming	NULL
growth	NULL
factor-B	NULL
activation	NULL
element	NULL
.	NULL

J	NULL
Bio/	NULL
Chem	NULL
268	NULL
,	NULL
13625	NULL
.	NULL

FerrEira	NULL
O.C	NULL
.	NULL

,	NULL
Vaumsky	NULL
JE	NULL
.	NULL

,	NULL
SHerinan	NULL
K.	NULL
,	NULL
WAyNER	NULL
EA	NULL
.	NULL

,	NULL
Bianco	NULL
C.	NULL
&	NULL
Garcta-Parpo	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Phorbol	NULL
ester-induced	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
enhances	NULL
attachment	NULL
to	NULL
fibronectin	NULL
©	NULL
1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
95	NULL
,	NULL
264-271	NULL
24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
and	NULL
fibronectin-induced	NULL
IL-1	NULL
$	NULL
B	NULL
and	NULL
distinctly	NULL
modulates	NULL
the	NULL
«	NULL
5B1	NULL
and	NULL
«	NULL
481	NULL
fibronectin	NULL
receptors	NULL
.	NULL

Exp	NULL
Cell	NULL
Res	NULL
193	NULL
,	NULL
20	NULL
.	NULL

Strurovict	NULL
B.	NULL
,	NULL
DantEL-IssakaAnt	NULL
S.	NULL
,	NULL
Oto	NULL
E.	NULL
,	NULL
Nestor	NULL
J.	NULL
,	NULL
CHan	NULL
H.	NULL
&	NULL
Tsou	NULL
AP	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Activation	NULL
of	NULL
distinct	NULL
protein	NULL
kinase	NULL
C	NULL
isozymes	NULL
by	NULL
phorbol	NULL
esters	NULL
:	NULL
correlation	NULL
with	NULL
induction	NULL
of	NULL
interleukin-1	NULL
beta	NULL
gene	NULL
expression	NULL
.	NULL

Biochemistry	NULL
28	NULL
,	NULL
3569	NULL
.	NULL

CHang	NULL
Z.L	NULL
.	NULL

,	NULL
D.H.	NULL
,	NULL
Personius	NULL
CD	NULL
.	NULL

&	NULL
Suen	NULL
ZL	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Fibronectin	NULL
cell-binding	NULL
domain	NULL
triggered	NULL
transmembrane	NULL
signal	NULL
transduction	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Leukoc	NULL
Bio/	NULL
53	NULL
,	NULL
79	NULL
.	NULL

PeErEz	NULL
RL	NULL
.	NULL

&	NULL
Roman	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Fibrin	NULL
matrices	NULL
enhance	NULL
the	NULL
expression	NULL
of	NULL
interleukin-1B	NULL
by	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

Implications	NULL
for	NULL
lung	NULL
granulomatous	NULL
inflammation	NULL
.	NULL

J	NULL
Immunol	NULL
154	NULL
,	NULL
1879	NULL
.	NULL

SHapriRa	NULL
L.	NULL
,	NULL
TakasHiBA	NULL
S.	NULL
,	NULL
CHAMPAGNE	NULL
C.	NULL
,	NULL
Amar	NULL
S.	NULL
&	NULL
Dyke	NULL
T.E.V	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Involvement	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
in	NULL
lipopolysaccharide-induced	NULL
TNF-alpha	NULL
and	NULL
IL-1	NULL
beta	NULL
production	NULL
by	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
153	NULL
,	NULL
1818	NULL
.	NULL

Vuort	NULL
K.	NULL
&	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
precedes	NULL
«	NULL
5B1	NULL
integrin-mediated	NULL
cell	NULL
spreading	NULL
on	NULL
fibronectin	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268	NULL
,	NULL
21459	NULL
.	NULL

PaorrRoack	NULL
A.D.	NULL
,	NULL
Roack	NULL
P.J	NULL
.	NULL

,	NULL
Zucker	NULL
KE	NULL
.	NULL

&	NULL
SwuitH	NULL
S.S.	NULL
(	NULL
1986	NULL
)	NULL
Selective	NULL
phosphorylation	NULL
of	NULL
human	NULL
DNA	NULL
methylitransfer-ase	NULL
by	NULL
protein	NULL
kinase	NULL
C.	NULL
FEBS	NULL
Lett	NULL
197	NULL
,	NULL
149	NULL
.	NULL

©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
95	NULL
,	NULL
264-271	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

271	NULL
Buras	NULL
J.A	NULL
.	NULL

,	NULL
Monks	NULL
B.G	NULL
.	NULL

&	NULL
Fenton	NULL
M.J.	NULL
(	NULL
1994	NULL
)	NULL
The	NULL
NF-bA-binding	NULL
element	NULL
,	NULL
not	NULL
an	NULL
overlapping	NULL
NF-IL-6-binding	NULL
element	NULL
,	NULL
is	NULL
required	NULL
for	NULL
maximal	NULL
IL-1B	NULL
gene	NULL
expression	NULL
.	NULL

J	NULL
Immunol	NULL
152	NULL
,	NULL
4444	NULL
.	NULL

BaxoucHE	NULL
O.	NULL
,	NULL
MorEaV	NULL
J.L	NULL
.	NULL

&	NULL
LacHman	NULL
LB	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Secretion	NULL
of	NULL
IL-1	NULL
:	NULL
role	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
J	NULL
Immunol	NULL
148	NULL
,	NULL
84	NULL
.	NULL

Geng	NULL
Y.	NULL
,	NULL
Zxang	NULL
B	NULL
.	NULL

&	NULL
Lotz	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Protein	NULL
tyrosine	NULL
kinase	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
lipopolysaccharide	NULL
induction	NULL
of	NULL
cytokines	NULL
in	NULL
human	NULL
blood	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
151	NULL
,	NULL
6692	NULL
.	NULL

Sipers	NULL
W.M	NULL
.	NULL

&	NULL
Mizet	NULL
S.B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Interleukin-1B	NULL
secretion	NULL
.	NULL

A	NULL
possible	NULL
multistep	NULL
process	NULL
that	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
cell	NULL
type-specific	NULL
manner	NULL
.	NULL

J	NULL
Bio/	NULL
Chem	NULL
270	NULL
,	NULL
16258	NULL
.	NULL

RUuBARTELLE	NULL
A.	NULL
,	NULL
Cozzoumo	NULL
F.	NULL
,	NULL
Taro	NULL
M.	NULL
&	NULL
Sita	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
A	NULL
novel	NULL
secretory	NULL
pathway	NULL
for	NULL
interleukin-1	NULL
beta	NULL
,	NULL
a	NULL
protein	NULL
lacking	NULL
a	NULL
signal	NULL
sequence	NULL
.	NULL

EMBO	NULL
J	NULL
9	NULL
,	NULL
1503	NULL
.	NULL

Sipers	NULL
WM	NULL
.	NULL

,	NULL
Kumovitz	NULL
J.C.	NULL
&	NULL
Mize	NULL
S.B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Characterization	NULL
of	NULL
the	NULL
structural	NULL
requirements	NULL
and	NULL
cell	NULL
type	NULL
specificity	NULL
of	NULL
IL-l1	NULL
«	NULL
and	NULL
IL-1	NULL
secretion	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268	NULL
,	NULL
22170	NULL
.	NULL

Hazupa	NULL
DJ	NULL
.	NULL

,	NULL
Strickrer	NULL
J.	NULL
,	NULL
Smon	NULL
P.	NULL
&	NULL
Young	NULL
P.R	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Structure-function	NULL
mapping	NULL
of	NULL
interleukin-1	NULL
precursors	NULL
.	NULL

Cleavage	NULL
leads	NULL
to	NULL
a	NULL
conformational	NULL
change	NULL
in	NULL
the	NULL
mature	NULL
protein	NULL
.	NULL

J	NULL
Bio/	NULL
Chem	NULL
266	NULL
,	NULL
7081	NULL
.	NULL

